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Due to their bioactivities and interesting structural features, tricyclic marine 
alkaloids as (–)-lepadiformine and (–)-fasicularine have been the subject of 
numerous synthetic studies. In this context, The planning and implementation of 
flexible, divergent total syntheses of pyrrolo-/pyrido[1,2-j]quinoline tricyclic 
marine alkaloids is presented. A functionally enriched intermediate was readily 
assembled by employing an ester-enolate Claisen rearrangement of the cyclic 
amino acid allylic ester possessing an exocyclic N-carbonyl group. This common 
intermediate was efficiently converted to (–)-lepadiformine A, (–)-fasicularin, and 
the proposed structure of recently isolated polycitorols A and B in a substrate-
controlled manner. In these studies, we also have shown that the configuration of 
polycitorols requires revision, proposed possible structure of natural polycitorol A.     
A key step in our synthesis was a reagent-dependent stereoselective 
intramolecular reductive amination of the common intermediate to yield either 
indolizidines, for syntheis of (–)-lepadiformine and (–)-fasicularin. In addition, less 
explored aziridinium-mediated carbon homologation of the hindered C-10 group 
into a homoallylic group greatly facilitated the synthesis.  
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Tricyclic marine alkaloids have been an attractive synthetic target for the last 
two decades. Some representative members of this class of natural products are 
cylindricines, lepadiformines, fasicularin. The first members of this structurally 
interesting naturally occurring product family are cylindricines (1, Figure 1), which 
were isolated from the ascidian Clavelina cylindrica by Blackman in the early 
1990s.1 Interestingly, pyrroloquinoline cylindricine A (1a) and pyridoquinoline 
cylindricine B (1b) exist as a 3:2 equilivrium mixture, presumably via the 
aziridinium intermediate 2. Another notable alkaloid of this general class is (–)-
lepadiformine A (3a). This marine alkaloid was isolated from the tunicate 
Clavelina lepadiformis off the coast of Tunisia by Biard in 1994 and was shown to 
be activity in the cardiovascular system in vivo and in vitro, as well as moderate 
cytotoxic activity toward various tumor cell lines in vitro.2 The original structure 
for lepadiformine A, proposed on the basis of NMR analysis (1H, 13C), was shown 
to be incorrect, and the correct relative and absolute stereochemistry was 
established to be 3a independently through pioneering efforts from Weinreb, and 
Kibayashi. by its total synthesis.3 The revised structure of lepadiformine A has a 
trans-1-azadecalin A/B ring system in constrast to a cis-1-azadecalin core of 
cylindricines and lack oxidation at the C-4 position. X-ray crystallographic analysis 
 2
of synthetic lepadiformine hydrochloride indicated that its B ring exists in an 
unusual twist-boat form as shown in Figure 1.3a 
 
 
Figure 1. Structures of tricyclic marine alkaloids. 
 
Since the isolation of cylindricines and lepadiformine A, two additional alkaloids 
closely related to lepadiformine A were isolated from the marine tunicate Clavelina 
moluccensis off the coast of Djibouti by the Sauviat group.4 These marine alkaloids 
lepadiformine B (3b), lepadiformine C (3c), which contain a four-carbon side chain 
instead of six-carbon of lepadiformine A. And lepadiformine C is lack 
hydroxymethyl moiety at C-13. In addition to these alkaloids, (–)-fasicularin (4) 
was discovered in 1997 by Patil and co-workers from the ascidian Neptheis 
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fasicularis.5 This alkaloid has selective activity against a DNA repair-deficient 
yeast and was shown to be cytotoxic activity against Vero cells.5 The structural 
features of fasicularin are related to those of cylindricine B (1b), but the A/B ring 
system is a trans-1-azadecalin similar to that of lepadiformines. Moreover, like 
lepadiformine A, this alkaloid lacks the carbonyl group at C-4. More recently other 
molecules with similar architectures to the cylindricines and lepadiformines, 
fasicularin were isolated from a marine ascidian of the family Polycitoridae and 
named polycitorols A and B by Tanaka and co-workers.6 Based on the spectral 
analysis, the structure of polycitorols was proposed as depicted in 5a and 5b. The 
proposed structures of polycitorols are similar to those of cylindricines, but they 
have a butyl group rather than hexyl at C-2 and lack the C-4 oxygenation found in 
the most cylindricines. As a consequence of the interesting bioactivities and 
intriguing structural features, these tricyclic marine alkaloids have been the subject 
of numerous synthetic studies.7,8  
In this context, we have previously reported a formal synthesis of lepadiformine A9 
that used a Claisen rearrangement and a ring-closing metathesis (RCM) as key 
steps. Herein, we wish to describe the full details of synthetic work that includes 
the concise and substrate-controlled total syntheses of (–)-lepadiformine A (3a) and 
(–)-fasicularin (4) via a common intermediate as well as the synthesis of the 
proposed structure of polycitorols (5). One of the key features employed in theses 
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total syntheses was a reagent-dependent reversal of diastereofacial selectivity in the 
formation of B-ring of the tricyclic marine alkaloids. This, together with the 
appropriate combination of functional groups in the A/B ring formation, enables us 
to selectively synthesize the above-mentioned alkaloids from the same intermediate. 
 
General synthetic strategy 
The main structural difference between tricyclic marine alkaloids 3–5 was the 
stereochemistry of the A/B ring fusion. To synthesize these alkaloids, we adopted a 
flexible approach that could prepare both cis and trans-1-azadecalin A/B ring 
systems. We envisioned that either cyclic amino acid 6a or its C-5 epimer 6b 
(Scheme 1) could potentially lead to both cis and trans-1-azadecalin A/B ring 
systems by the appropriate combination of functional groups.  
For example, a trans-1-azadecalin A/B ring system of 3 and 4 could be 
constructed from cyclic amino acid 6a through a ring closure involving the 
formation of a bond between the C-5 vinyl group (natural product numbering) and 
the C-10 carboxylic group along with the formation of the piperidine B-ring by 
joining the nitrogen function to the C-5 propanol moiety. Alternatively, ring closure 
by annulation of the C-10 carboxylic group with the C-5 propanol moiety and 
piperidine B ring formation involving the nitrogen and C-5 vinyl group would lead 
to the formation of the cis-fused A/B ring system of the polycitorols (5).  
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Scheme 1. General retrosynthetic analysis. 
 
With cyclic amino acid 6b, a trans-fused A/B ring system would be obtained by 
ring closure through annulation of the C-10 carboxylic group with the C-5 propanol 
moiety and piperidine ring formation involving the nitrogen and the C-5 vinyl 
group. The ester-enolate Claisen rearrangement of amino acid allylic ester 7 was 
envisioned to deliver the densely functionalized cyclic amino acids 6a or 6b. The 
stereochemical outcome of the Claisen rearrangement of 7 can be determined from 
the enolate geometry and transition-state geometry. The Claisen rearrangement 
proceeds via a chairlike transition state.10 However, at the beginning of our studies, 
there were no examples in the literature describing the control of the ester-enolate 
geometry in cyclic a-amino acid ester compounds possessing an exocyclic N-
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carbonyl group such as 7.11 Therefore, we were uncertain about the stereochemistry 
of the major product formed from the rearrangement of 7. However, the 
stereochemical outcome was not a concern if high selectivity was achieved because 
both C-5 epimer 6a and 6b could be transformed to either the cis- or trans-1-

















II. Results and Discussion 
 
Synthesis of key intermediate 6 
As per the general synthetic plan, our synthesis started with the preparation of 
synthetic precursor 8 for the Claisen rearrangement substrate 7 (Scheme 2). The 
protected cyclic amino acid 8 was the only source of chirality in our synthesis. 
Although the stereochemistry at the a-position of the carbonyl group of 8 would 
be destroyed upon deprotonation during the ester-enolate Claisen rearrangement, 
the amino acid 8 was prepared as single configuration product in a four-step 
sequence from commercially available (S)-methyl-N-Boc-pyroglutamate 9. The 
DIBAL-H reduction of 9 was followed by in situ treatment with acidic methanol, 
affording aminal 10. The hydroxyl group of 10 was protected as its benzyl ether to 
give the known compound 11.12 The stereoselective nucleophilic addition of a 
vinyl group to the N-acyliminium ion generated in situ from 11 was achieved by 
employing a Grignard-derived vinylcopper reagent in the presence of BF3·Et2O to 
produce 12 as the only detectable isomer in 92% yield. The vinyl moiety of 12 was 
transformed to a carboxylic acid group by ruthenium tetraoxide-mediated oxidative 
cleavage to give amino acid 8 in 83% yield.13 Esterification of acid 8 with known 
allylic alcohol 1314 under Steglich’s DCC coupling15 conditions provided the 
desired allylic ester 7 in high yield. With multigram quantities of 7 in hand, we 
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explored the ester-enolate Claisen rearrangement. One of the important 
requirements for the stereoselective installation of the new stereocenters was the 
selective production of E or Z enolates from 7 prior to the rearrangement occurring 
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Scheme 2. Synthesis of the key intermediate 6a via Claisen type rearrangement. 
 
However, there were no examples in the literature, by that time, describing the 
control of the ester-enolate geometry in cyclic α-amino acid ester compounds 
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possessing an exocyclic N-carbonyl group. Thus, we surveyed a series of reaction 
conditions, involving changes in base, additive, temperature, and solvent, in the 
hope of achieving the high stereoselectivity in the formation of either 6a or 6b via 
selective enolization. 
Some typical results of the ester-enolate Claisen rearrangement are summarized in 
Table 1. In all the reaction conditions tested, the major product was the 
rearrangement product 6a and the minor one was its stereoisomer 6c. The other two 
possible isomers 6b and 6d, theoretically resulting from a (Z)-ketene acetal 
configuration in the chair-like transition state, were not detected even in the 
reactions with HMPA (Table 1, entries 4 and 5).  
Due to the clear predominance of the chair conformation in the transition state of 
the Claisen rearrangement, the outcome of 6a and 6c indicated the exclusive 
formation of the (E)-ketene acetal as an intermediate during the reaction. The 
reasons for this selective enolization might be due to the unfavorable steric 
interaction between the bulky N-Boc group and the alkyl group of the ester moiety 
in the transition state leading to the (Z)-ketene acetal.16 Another plausible 
explanation for this selectivity is chelation control between the (E)-ester enolate 




Table 1. Reaction conditions of Claisen rearrangement of 7. 
entry base additive solvent  yield (%),
a 
1c LiHMDS – THF 90%, 10:1 
2c KHMDS – THF 80%, 3:1 
3c LDA – THF 60%, 3:1 
4c LiHMDS – THF/HMPA 60%, 5:1 
5c LDA – THF/HMPA 40%, 3:1 
6d LiHMDS TBSCl THF 88%, 8:1 
7d NaHMD TBSCl THF 85%, 4:1 
8d KHMDS TBSCl THF 70%, 5:1 
9d LDA TBSCl THF 50%, 2:1 
 aIsolated yields. bDetermined by 1H NMR analysis of the crude reaction 
mixture. cSubstrate was added to a solution of base at –78 °C. Solvent 
(0.05 M). dBase was added to a solution of sub-strate at –78 °C, and th
en additive was added. Solvent (0.02 M). 
 
The stereochemistry of rearrangement product 6a was established by its conversion 
to the final natural product (vide infra), and the stereochemistry of 6c was 
determined by NOE experiments after conversion to a rigid bicyclic compound 15 
(figure 2).18  The major product 6a resulted from rearrangement on the less-
hindered face opposite the C-13 substituent. The facial selectivity of this process 
was dependent on the nature of the bases. LiHMDS yielded better results as the 
base than LDA (Table 1, entry 1 vs. 3 and 6 vs. 9). The reactions conducted with 
LiHMDS occurred with higher selectivity than those conducted with NaHMDS or 
KHMDS (entry 6 vs. entries 7 and 8).  
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Figure 2. Synthesis of bicyclic compound 15. 
Figure 3. (a) Synthesis of Bicyclic Compound 15 (b) NOESY spectrum (400 MHz) of 15 in CDCl3 
at room temperature. The off-diagonal peaks of interest are indicated by red boxes. The molecular 
structure of 15 and observed correlations in its NOESY spectrum are shown. 
 
The reasons for this selectivity are not yet clear. The best reaction conditions in 
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terms of both yield and selectivity were as follows. When substrate 7 was added to 
a solution of LiHMDS in THF at –78 oC and gradually warmed to room 
temperature, a very high diastereofacial selectivity was achieved in the 
rearrangement to afford 6a and 6c in a 10:1 ratio and 90% combined yield (Table 1, 
entry 1). Similarly high yields and selectivity were obtained when the mixture of 7 
and TBSCl was treated with LiHMDS in THF at –78 oC followed by gradual 
warming to room temperature (entry 6). 
 
Formal synthesis of (–)-lepadiformine A with the rearrangement 
product 6a9 
The tricyclic amino nitrile 16 (Scheme 4) was a key advanced intermediate in 
Weinreb’s total synthesis of lepadiformine A.3b We envisioned that this 
intermediate could be readily synthesized from the functionalized cyclic amino 
acid 6a, the major product of Claisen rearrangement of 7. As mentioned earlier, a 
ring closure by bonding between the C-5 vinyl group and the C-10 carboxylic 
group of 6a would yield the desired ring system of lepadiformines. We planned to 
use a RCM reaction19 for this ring closure. For the preparation of the metathesis 
precursor, we first turned our attention to the conversion of the carboxylic acid 




Scheme 3. Synthesis of RCM precousor. 
 
To this end, methylation of the carboxylic acid 6a with MeI/K2CO3 in acetone 
afforded the ester 18 (93%), which carboxylic ester 18 was reduced with LiAlH4 to 
the corresponding primary alcohol 19 (94%). Unfortunately, all of our attempts to 
convert the primary alcohol group in 19 to the homoallyl group in 17 were 
unsuccessful, presumably because of the high degree of steric hindrance. The 
above failure forced us to devise an alternative RCM substrate 20. We envisioned 
that two-carbon-atom-homologation of the C-5 vinyl group and conversion of a C-
10 carbonyl function to a carbon-carbon double bond would provide the 
appropriate substrate for the RCM reaction. A one-pot tandem sequence involving 
regioselective hydroboration of the terminal olefin in 18 with by coupling of the 
resulting borane under Suzuki–Miyaura conditions ([PdCl2(dppf)], AsPh3) 
(dppf=1,1’-bis(diphenylphosphino)ferrocene) with vinyl bromide yielded 21 in 
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73% overall yield.20 Treatment of 21 with LiAlH4 effected the reduction of ester to 
afford the alcohol 22 in 91% yield. Swern oxidation of 22, followed by a Wittig 
reaction of the resulting hindered aldehyde with methylidene triphenylphosphorane, 
successfully provided the desired RCM substrate 20 in 84% overall yield.  
The RCM of diene 20 was successfully performed with a second-generation 
Grubbs’ catalyst21 in CH2Cl2 at –40 °C, furnishing the desired azaspiro-
cyclohexene derivative 23 in excellent yield (98%). Hydrogenation of the olefinic 
bond of 23 using H2 and 10% Pd/C in the presence of Et3N as a catalyst poison 
afforded 24 without effecting hydrogenolysis of the O-benzyl protecting group.22  
 
 
Scheme 4. Fomal synthesis of (–)-lepadiformine A. 
 
After the carbocyclic A-ring formation, we directed our efforts toward the 
construction of the cyano group-functionalized lepadiformine B-ring to complete 
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the formal synthesis. Deprotection of the silyl ether 24 with TBAF, followed by 
oxidation of the resultant alcohol 25 with Dess–Martin periodinane23 gave 
aldehyde 26 in 95% overall yield. Treatment of 26 with p-TsOH in aqueous acetone 
under reflux led to removal of the Boc protecting group and subsequent cyclization 
to the unstable tricyclic enamine 27, which has been previously reported by the 
Weinreb group.3b Without purification, we employed reaction coditions analogous 
to those used by Weinreb, to convert 27 into the more stable α-amino nitrile 16 in 
70% overall yield. Our 1H and 13C NMR spectro-scopic data for 16 were identical 
with those reported previously. Thus, we have accomplished a formal synthesis of 
(–)-lepadiformine A and could confirm the relative stereochemistry of 6a. 
 
Formal synthesis of (–)-fasicularin 
In Weinreb’s total synthesis, compound 16 has been converted to lepadiformine A 
in two steps as shown in Scheme 5.3b In this sequence, the hexyl group was 
introduced into 16 using hexylmagnesium bromide in the presence of boron 
trifluoride etherate to afford the desired alkylation product 28a and its C-2 epimer 
28b (Scheme 5) in a 3:1 ratio. Preference for the formation of 28a could be 
rationalized by Stevens’ stereoelectronic principle,24 and the modest 
diastereoselectivity might be a result of the severe 1,3-diaxial interaction between 
the incoming nucleophile and the bridge carbon (C-11) during the preferred axial 
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attack of the nucleophile on the iminium intermediate 29. 
 
 
Scheme 5. Synthesis of lepadiformine by Weinreb. 
 
These stereochemical outcomes in the reaction of tricyclic iminium intermediate 
29 give us implications for the synthesis of (–)-fasicularin (4) from aldehyde 26. 
We envisioned that the reduction of iminium species 30 (Scheme 6) from the 
stereoelectronically preferred face would provide a C-2 stereochemistry for 
fasicularin. The expected product 28b would convert into pyridoquinoline alkaloid 
4 via aziridinium intermediate 31 by Kibayashi and co-workers.3a,25 
Toward the synthesis of (–)-fasicularin (4) from aldehyde 26, the hexyl group was 
first introduced using hexylmagnesium bromide to afford alcohol 32 as a 1:1 
mixture of diastereomers in 92% yield. Secondary alcohol 32 was oxidized with 
the Dess–Martin periodinane to give ketone 33 (93%). For the annulation of the B-
ring by reductive amination, the N-Boc protecting group of 33 was removed with 
TFA to afford iminium salt 30, and the resultant salt was treated with NaCNBH3 in 




Scheme 6. Formal Synthesis of (–)-Fasicularin. 
 
The spectroscopic data for compound 28b synthesized by this route were identical 
to those previously reported.25 The remaining steps to complete the synthesis were 
the removal of benzyl protecting group to give 34 and the formation of the 
thiocyanate-bearing C-ring via aziridinium intermediate 31. These steps were 
accomplished by employing the same reaction conditions as in literature.25 Because 
the C-2 epimer 28a of 28b could be converted to lepadiformine A in a single step, 
some efforts were made to invert the diastereoselectivity in hope of development of 
a selective new route to lepadiformine A. We envisioned that the employment of 
the bulky reducing agent would invert the selectivity, because the reduction of 
iminium ion 30 by the bulky reducing agent could occur through a twisted-boat 
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conformation (equatorial attack) to avoid the severe 1,3-diaxial interaction between 
the bridge carbon (C-11) and the incoming agent. However after attempts with 
various hydride reagents, it was realized the diastereofacial preference of reductive 
amination of iminium salt 30 could not be reversed. When the reduction was 
carried out with H2 and Pd/C in the presence of Et3N, the diastereoselectivity was 
reduced to 3:1 but not inverted. When iminium salt 30 was treated with the bulky 
L-Selectride, the reduction product was not the product of reductive amination, but 
the secondary alcohol 35 (ca. 1:1 mixture).  
 
Revised synthetic approach to (–)-lepadiformine A and (–)-fasicularin 
Although we have successfully accomplished a formal synthesis of (–)-
lepadiformine A and (–)-fasicularin, the synthesis suffered from the long synthetic 
sequences. Our eventual goal of this second round of synthesis was the 
accomplishment of concise and selective synthesis of both (–)-lepadiformine A (3a) 
and (–)-fasicularin (4) from the same intermediate in a substrate-controlled manner.     
In our preceding synthesis, the reductive amination of tricyclic substrate 33 
resulted in the predominant formation of pyrroloquinoline 28b. Its C-2 isomer 28a 
for lepadiformine was obtained only as a minor product. From these results, we 
concluded that formation of the azaspirocyclic skeleton prior to the annulation of 
the B-ring by reductive amination does not appear to be an adequate synthetic route 
 19








































Scheme 7. Revised synthetic approach. 
 
Thus, in the new approach, the formation of A-ring was postponed until the B ring 
of the tricyclic alkaloid was constructed by reductive amination as shown in 
Scheme 7.   
 
Model system for a unified route to both (–)-lepadiformine (3a) and (–)-
fasicularin (4) 
Before starting the second round of total synthesis, an appropriate model system 
was developed to determine if the revised sequence would provide adequate 
control of the stereochemistry at C-2. Therefore, we chose pyrrolidine derivatives 
37a–c18 (Table 2) as the reductive amination/cyclization precursors. The first model 
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compound, 37a, has no substituent at C-10 (lepadiformine numbering), while the 
second one, 37b, has an ester substituent, similar to the real system. Compound 37c 
has a hydroxyl methyl group protected with a nonchelating bulky silyl group at the 
C-10 position. For the intramolecular reductive amination, the N-Boc protecting 
groups of the model compounds were removed with TFA to afford iminium salt 38, 
and the resulting salt was subjected to various reduction conditions to give 
indolizidines 39. The results are summarized in Table 2. Regardless of the nature of 
the reducing agent, compound 37a, which has no substituent at C-10, led to the 
exclusive formation of cis-39a, where the C-10 and C-2 hydrogen atoms have a cis 
arrangement (Table 2, entries 1–5). However, when the reduction was carried out 
with 37b, which has a substituent at C-10, reagentdependent stereoselectivity was 
observed. For example, upon addition of NaCNBH3 at room temperature, 
indolizidine cis-39b was obtained as the major reductive amination product of 
which C-10 and C-2 hydrogens have a cis arrangement (entry 6). Higher selectivity 
was obtained at lower temperatures (entries 7 and 8). Reduction in THF yielded a 
higher selectivity than that in MeOH (entries 8 vs. 9). When NaBH4 and 
Na(OAc)3BH were employed as the reducing agent, a high diastereofacial 
selectivity for cis-39b was also observed (entries 10 and 11). On the other hand, 
when iminium salt 38b was treated with the bulky reducing agent L-Selectride, the 
diastereofacial selectivity was completely inverted (entry 12).  
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Table 2. Model system study for reductive amination. 
 
entry substrate reducing agent solvent T (oC) 
yield (%),a  
cis:trans  
1 37a NaCNBH3 MeOH –40 78%, 1:0 
2 37a NaBH4 MeOH –40 85%, 1:0 
3  37a Na(OAc)3BH MeOH –40 85%, 1:0 
4  37a L-Selectride THF –78 80%, 1:0 
5  37a Pd/C  MeOH rt 90%, 1:0 
6  37b NaCNBH3 MeOH rt 83%, 5:1 
7 37b NaCNBH3 MeOH 0 80%, 7.3:1 
8 37b NaCNBH3 MeOH –40 92%, 24:1 
9 37b NaCNBH3 THF –40 76%, 74:1 
10 37b NaBH4 MeOH –40 80%, 9.5:1 
11 37b Na(OAc)3BH MeOH –40 85%, 7:1 
12  37b L-Selectride THF –78 75%, 1:11 
13 37b Pd/C  MeOH rt 73%, 1:12 
14 37b LiEt3BH THF –78 95%, 1:2.3 
15 37c NaCNBH3 MeOH –40 89%, 3:1 
16 37c NaBH4 MeOH –40 91%, 5:1 
17 37c Na(OAc)3BH MeOH –40 89%, 2.4:1 
18 37c L-Selectride THF –78 80%, 1:7 
19 37c LiEt3BH THF –78 90%, 1:2 
20 37c Pd/C  MeOH rt 93%, 1:22 
a Yields and ratio were determined by GC analysis.  
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In this reduction conditions, indolizidine trans-39b was the major isomer and was 
obtained in a ratio of 1:11 with a combined yield of 75%. The reductive amination 
under catalytic hydrogenation conditions also yielded trans-39b as a major isomer 
with high selectivity (entry 13), while the reaction with LiEt3BH afforded low 
diastereoselectivity (entry 14). Substrate 37c also exhibited reagent-dependent 
stereoselectivity (entries 15–20), and the diastereofacial selectivity pattern was the 
same as that observed for 37b. However, the level of selectivity was generally 
lower, presumably due to the different nature of C-10 substituents, except for the 
catalytic hydrogenation (entry 20). To our knowledge, this hydride reagent-
dependent reversal of diastereofacial selectivity in the formation of indolizidine 
and similar ring system has not yet appeared in the literature, and we believe that 
our result is the first example of this occurrence. This complete reversal of 
stereochemistry in the reductive amination reaction could be explained by both 
steric and stereoelectronic factors. Iminium salt 38 could exist in either of two half-
chair conformations 38′A and 38′B as shown in Figure 3. Our theoretical 
calculations predicted that 38′A was more stable than 38′B regardless of the 
substituent at C-10.26 Therefore we expected that iminium salt 38 would exist 
predominantly in conformation 38′A at reaction temperature. According to the 
stereoelectronic principles delineated by Stevens,24 the addition of the hydride 
reagent to the iminium moiety should take place from the stereoelectronically 
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preferred face of 38′A (path a) via a chair-like transition state to give 39-cis. 
However, in the case of a bulky reducing agent, “axial attack” (Figure 3, path a) 
would be disfavored due to severe steric interactions between the incoming bulky 
reagent and the C-10 substituent group. 
 
  
Figure 3. Two half-chair conformations of iminium salt 38 and reaction pathways to 39. 
 
Thus, “equatorial attack” (Figure 3, path b) through a twisted-boat conformation, 
which would lead to the formation of trans-39, might be more sterically favored in 
the case of a bulky hydride donor and C-10 substituted substrate.  
Another possible mechanistic path via the less stable conformer 38′B cannot be 
completely ruled out. If the reaction rate through conformer 38′A is considerably 
slower than the interconversion rate of the two conformers, the reduction of the 
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iminium ion by the bulky reducing agent would occur from the less stable 
conformer 38′B, as stated by the Curtin–Hammett principle.27 Therefore, it is not 
unreasonable to postulate that reduction by L-Selectride can also occur from the 
stereoelectronically preferred face of conformer 38′B (Figure 3, path c) to yield 
indolizidine trans-39. 
 
Synthesis of the B/C ring system of (–)-lepadiformine and (–)-
fasicularin 
With the opportunity to access both C-2 epimers, we initiated the second round of 
total synthesis. In our new synthesis, instead of utilizing Claisen rearrangement 
product 6a, a more elaborate rearrangement product 40 (Scheme 7) was devised for 
the concise synthesis. Thus, our synthesis began with the preparation of allylic 
alcohol 41 for the new Claisen rearrangement substrate 42.  
For the synthesis of 42, we utilized known ketone 43,28 which was readily 
synthesized in three steps from commercially available g-decanolactone. The 
ketone group of 43 was protected as the ethylene ketal, and then the ester group 
was then reduced with DIBAL-H to provide allylic alcohol 41 in 77% overall yield. 
Esterification of acid 8 with allylic alcohol 41 under EDCI coupling provided 
allylic ester 42. (88%) With compound 42 in hand, we performed the ester-enolate 






































































Scheme 8. Synthesis of reductive amination substrate 44. 
 
Treatment of 42 with LiHMDS in THF at –78 oC and gradual warming to room 
temperature afforded, after esterification with TMSCHN2, the desired 
rearrangement product 44 and a minor amount of its stereoisomer in 88% 
combined yield and 10:1 diastereoselectivity.  
For the intramolecular reductive amination, the N-Boc and ketal protecting groups 
of 44 were simultaneously removed with TFA to yield iminium salt 45. In the light 




Scheme 9. Synthesis of indolizidine 36a, 36b. 
 
When the reduction was carried out with NaCNBH3 at –78 
oC, reductive amination 
product 36a was obtained along with a minor amount of its stereoisomer 36b in 
87% combined yield and high diastereoselectivity (12:1).29 On the other hand, 
when iminium salt 45 was treated with the bulky reducing agent L-Selectride at –78 
oC, the diastereofacial selectivity was completely inverted. In this reduction 
condition, indolizidine 36b was the major isomer, formed in a ratio of 1:24 and 
91% combined yield. 
 
Total synthesis of (–)-lepadiformine and (–)-fasicularin 
Having achieved the stereoselective formation of both diastereoisomers 36a and 
36b, we next focused our efforts on the construction of A ring through an RCM 
reaction to complete the synthesis. Towards the total synthesis of (–)-fasicularin (4), 
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the ester of 36b was reduced with LiAlH4 to the corresponding primary alcohol 
46b, in 96% yield (Scheme 10). Despite considerable steric hindrance, we 
successfully converted the hydroxymethyl group of 46b to the homoallyl group in 
47b via anchimeric assistance by the tertiary amine within the molecule. Treatment 
of 46b with MsCl in the presence of Et3N resulted in the unstable aziridinium salt 
48b. This was treated with the allyl cuprate, derived from allylmagnesium bromide 
and CuI, which regioselectively attacked the reactive aziridinium ion at the 















































-78 oC to 0 oC
LiAlH4
 
Scheme 10. Completion of the synthesis of (–)-fasicularin. 
 
Although aziridinium ions are well established intermediates,30 their reactions 
with a hard carbon nucleophile are much less general and have been less widely 
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applied to the synthesis.31 Thus, we believe that this successful aziridinium-
mediated carbon homologation at a sterically hindered position will increase the 
utility of the aziridinium ion in the synthesis of complex nitrogen-containing 
compounds. The RCM of diene 47b was successfully performed, furnishing the 
desired tricyclic compound 49b in very high yield (90%). Catalytic hydrogenation 
of 49b over Pd/C resulted in the reduction of the olefinic bond and removal of the 
benzyl protecting group to give tricyclic compound 34 in 92% yield. The 
spectroscopic data for compound 34 synthesized by this route were identical to 
those reported previously.25 The remaining step to complete the synthesis was the 
formation of the thiocyanate-bearing C ring, and this was accomplished by 
employing the same reaction conditions as in literature.25 The spectral and optical 
rotation data of synthetic (–)-4 were in good agreement with reported values.5,25  
 
 
Scheme 11. Completion of the synthesis of (–)-lepadiformine. 
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With the synthesis of (–)-fasicularin (4) accomplished, we next turned to the 
synthesis of (–)-lepadiformine A (3a) from indolizidine 36a (Scheme 11). 
For the construct the A-ring, we used the same methodology as applied to 
fasicularin. Thus, the ester of 36a was reduced to alcohol 46a (97%). Once again, 
aziridinium ion-mediated allylation provided the corresponding RCM substrate 47a, 
in 65% overall yield.32 In this process, unlike for aziridinium salt 48b, the 
aziridinium intermediate 48a was rather stable. The RCM of diene 47a followed by 
hydrogenation led to the formation (–)-lepadiformine A (80%), whose spectral data 
(1H and 13C) were in complete agreement with those reported in literature.2a,25 The 
optical rotation of synthetic lepadiformine also agreed with that found in the 
literature.  
 
Synthesis of the proposed structure of polycitorols with rearrangement 
product 6a 
The total synthesis of the proposed structure of polycitorols has not been 
previously reported. The A/B ring fusion of polycitorols was proposed to be cis, 




Scheme 12. Retrosynthetic analysis of polycitorol A, B. 
 
As mentioned earlier, cis-1-azadecalin A/B ring system of 5 would be accessible 
from the major product 6a of Claisen rearrangement via a ring closure by 
annulation of the carboxylic group with the C-5 propanol moiety and the piperidine 
B ring formation by using the nitrogen and the vinyl group. The formation of the B 
ring was expected to be achievable through reductive amination of the appropriate 
carbonyl group derived from the vinyl group of 6a. We planned to construct the 
piperidine B ring prior to the A ring of polycitorols, because we envisaged that this 
sequence would provide more adequate control of the stereochemistry at C-2. To 
this end, we first convert carboxylic acid moiety of Claisen rearrangement product 
6a into carboxylic ester through methylation.  
For the transformation of 18 into the reductive amination substrate 50, the vinyl 
group of 18 was converted to the corresponding aldehyde by ozonolysis and the 
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resultant aldehyde 51 was subjected to a Horner–Emmons olefination33 to give the 
a,b-unsaturated carbonyl compound 52 in 70% yield. Catalytic hydrogenation of 
52 over Pd/C resulted in the reduction of the double bond and simultaneous O-
benzyl group cleavage to afford reductive amination substrate 50 (85%).  
 
 
Scheme 13. Synthesis of reductive amination product 53a. 
 
For the intramolecular reductive amination, the N-Boc protecting group of 50 was 
removed with TFA. Next, in the light of the model system study, the crude salt was 
treated with hydride reagents. The reaction with NaCNBH3/AcOH in CH3CN at –
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78 oC resulted in good diastereoselectivity to yield indolizidines 53a and 53b in a 
ratio of 5:1. In other solvents, such as MeOH, THF, and CH2Cl2, the selectivity 
decreased to approximately 3:1. The C-2 stereochemistry of the two diastereomers 
was determined by NOESY analysis.18 The preference for the formation of 53a can 
be rationalized by Stevens’ stereoelectronic principle25 and substituent-directing 
effects. Intermediate iminium salt 55 would exist predominantly in the half-chair 
conformation as shown in Scheme 13. The preferred axial attack by the hydride 
reagent is validated by Stevens’ stereoelectronic principle. In addition, in this case, 
the hydride donor might be delivered also to the stereoelectronically preferred face 
by a nearby directing group, such as a hydroxyl group.  
Next, we focused our efforts on the construction of the A ring with the C-10 
carboxylic group and the C-5 propanol moiety of 53a. First, the hydroxyl group of 
53a was internally protected as the lactone by treatment with NaH (Scheme 14). 
Deprotection of silyl ether 56 followed by Appel reaction of the resultant alcohol 
57 yielded iodide 58. The obtained iodide 58 was subjected to a halogen-metal 
exchange to effect anionic cyclization.34 Treatment of 58 with t-BuLi at very low 
temperature produced the desired tricyclic product 59 in 60% yield. Finally, 
compound 59 was converted to the proposed structure (polycitorol A (5a)) by 
Wolff–Kishner–Huang reduction35 of its hindered carbonyl group at C-9.  
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Scheme 14. Synthesis of polycitorol A, B. 
 
The transformation of the obtained compound 5a into the proposed structure of 
polycitorol B (5b) proposed structure could be realized by using a protocol 
developed Cossy and Pardo.36 When 5a was heated in a sealed tube with a catalytic 
amount of TFAA in THF, it yielded the ring-expanded product 5b presumably via 
aziridinium intermediate. In this reaction, only one stereoisomer was observed as 
the final product. The spectral data for 5a and 5b were in good agreement with the 
assigned structures. However, disappointingly the spectroscopic data for synthetic 
compounds 5a and 5b did not match those reported for the natural products.6 So, to 
confirm stereochemistry of synthetic 5a, we first searched the stereoisomers of 
lepadiformine, which differ only in the length of the alkyl chain (i.e., hexyl vs. 
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butyl). Compund 60, which has been synthesized by the Pearson group as part of 
their efforts toward the structural revision of the originally proposed lepadiformine 
structure is identical the stereochemistry our synthetic product 5a, and 1H NMR 
spectra of its hydrochloride salt was reported.37 After hydrochloride salt formation 
of synthetic product 5a, the spectral data (1H NMR) compared with reference 
compound 60, which were in good agreement. Based on these result, could implied 
that the structures of the natural polycitorols had been assigned incorrectly. Besides 
compound 60, five other isomers have been synthesized including the natural 
isomer. Out of the eight possible diastereomer, only two diastereomers (i.e., 61 and 
62 in Figure 4) have not been reported. Because the pattern of the NMR spectra of 
the butyl group is similar to that of the hexyl group, the NMR pattern of polycitorol 
A would be very close to that of lepadiformine A. Thus, we compared the NMR 
spectroscopic data for polycitorol A with those for the reported isomers of 
lepadiformine A (3a). A thorough examination of the reported data of the six 
isomers with those of polycitorol A revealed only the differences.  
This NMR data analysis implied that the configuration of one of the two 
previously unreported isomers might be that of natural polycitorol A with a high 
probability. Our speculated structures of natural polycitorol A (i.e., 5a′ and 5a′′) 
might be assembled from Claisen rearrangement product 6c by the appropriate 
combination of functional groups at C-10 and C-5. However, compound 6c was the 
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minor product of the reaction.  
 
 
Figure 4. (a) Eight possible diastereomer. (b) Comparison of the NMR spectra of 5a.  
 
Unfortunately, we were unable to reverse the diastereoselectivity. Therefore, our 





In conclusion, We have planed and impled flexible, divergent total syntheses of 
pyrrolo-/pyrido[1,2-j]quinoline tricyclic marine alkaloids. A functionally and 
stereochemically enriched intermediate was concisely and stereoselectively 
assembled by employing an ester–enolate Claisen rearrangement reaction of the 
cyclic amino acid allylic ester possessing an exocyclic N-carbonyl group. This 
common intermediate was readily converted to (–)-lepadiformine A, (–)-fasicularin, 
and the proposed structure of polycitorols A and B in a substrate-controlled manner. 
In these studies, we have shown that the constitution of polycitorols requires 
revision. With the more elaborate ester-enolate Claisen rearrangement product, the 
more concise and selective synthesis of both lepadiformine A and fasicularin was 
also achieved in a substrate and reagentcontrolled manner. One of the key features 
employed in these total syntheses was a hydride reagent-dependent reversal of 
diastereofacial selectivity in the formation of the indolizidine, which we believe is 
the first example of this occurrence. In addition, aziridinium-mediated carbon 
homologation of the hindered C-10 group into a homoallylic group greatly 







All chemicals were reagent grade and used as purchased. All reactions were 
performed in an inert atmosphere of dry argon or nitrogen using distilled dry 
solvents. Reactions were monitored by TLC analysis using silica gel 60 F-254 TLC 
plates. Melting points are uncorrected. Flash column chromatography was carried 
out on silica gel (230–400 mesh). Optical rotations were measured using sodium 
light (D line 589.3 nm). 1H NMR (500 or 400 or 300 MHz) and 13C NMR (125 or 
100 or 75 MHz) spectra were recorded in  units relative to the non -deuterated 
solvent as an internal reference. IR spectra were measured on a Fourier Transform 
Infrared spectrometer. High resolution mass spectra (HRMS) were recorded using 
fast atom bombardment (FAB), or chemical ionization (CI). GC analyses were 
performed on a YL 6100-GC chromatograph equipped with a HP-5 column (30 m 
× 0.32 mm I.D.).
 38
IV-1. Synthesis of the key intermediate 6a 
IV-1-1. Synthesis of amino acid 8 from (S)-methyl-N-Boc-pyroglutamate 9. 
 
The protected amino acid 8 was prepared in a four-step sequence starting from 
commercially available (S)-methyl-N-Boc-pyroglutamate. The DIBAL-H reduction 
of the (S)-methyl-N-Boc-pyroglutamate was followed by in situ treatment with 
acidic methanol, giving the aminal 10. The hydroxyl group of 10 was protected as 
its benzyl ether to give the known compound 11. The stereoselective nucleophilic 
addition of a vinyl group to the N-acyliminium ion generated in situ from 11 was 
achieved by employing a Grignard-derived vinylcopper reagent in the presence of 
BF3·Et2O to produce 12 as the only detectable isomer in 92% yield. The vinyl 
moiety of 12 was transformed into a carboxylic acid group by the ruthenium 
tetraoxide mediated oxidative cleavage to give the previously reported amino acid 




(2S)-tert-butyl 2-(hydroxymethyl)-5-methoxypyrrolidine-1-carboxylate (10). 
 
To a solution of (S)-methyl-N-Boc-pyroglutamate 9 (10.0 g, 40.3 mmol) in dry 
CH2Cl2 (150 mL) was added DIBAL-H (161 mL, 161 mmol, 1.0 M solution in 
toluene) at –78 °C. After being stirred for 30 min at –78 °C, the reaction mixture 
was warmed to rt and stirred for 2 h. The reaction was quenched with MeOH at 
0 °C. The resulting white emulsion was slowly poured into ice-cold 2.0 M HCl 
solution and swirled over 2 h. It was diluted with EtOAc, washed with water, dried 
over MgSO4, filtered, and concentrated under reduced pressure. The resulting 
residue was purified by flash column chromatography on silica gel (hexane/EtOAc, 
4:1) to give the known 10 (6.60 g, 70%) as a colorless oil.  
 
(2S)-tert-butyl 2-(benzyloxymethyl)-5-methoxypyrrolidine-1-carboxylate (11). 
 
To a solution of 10 (6.00 g, 25.9 mmol) in anhydrous DMF (80 mL) was added 
NaH (2.07 g, 51.8 mmol, 60% dispersion in mineral oil) at 0 °C. The reaction 
mixture was stirred for 20 min and benzyl bromide (6.16 mL, 51.8 mmol) was 
added at 0 °C. The resulting mixture was stirred at rt for 1 h. The reaction was 
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quenched with aqueous saturated NH4Cl solution and extracted with CH2Cl2 twice. 
The combined organic layers were washed with brine, dried over MgSO4, and 
concentrated under reduced pressure. The resulting residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 10:1) to give the known 11] 
(7.05 g, 85%) as a colorless oil.  
 
(2S,5S)-tert-butyl 2-(benzyloxymethyl)-5-vinylpyrrolidine-1-carboxylate (12). 
 
To a suspension of copper iodide (14.2 g, 74.6 mmol) in anhydrous THF (100 
mL), at –40 °C under N2 atmosphere, was added dropwise a solution of the 
vinylmagnesium bromide (150 mL, 150 mmol, 1.0 M solution in THF). The 
solution was stirred for 20 min at 0 °C, then the reaction mixtures was cooled to –
78 °C, and a solution of 11 (6.00 g, 18.6 mmol) in anhydrous THF (30 mL) was 
added dropwise. After 5 min, BF3·OEt2 (9.36 mL, 74.6 mmol) was added. The 
reaction mixture was stirred for 2 h at –78 °C and slowly warm to rt over a period 
of 3 h. After 1 h at rt, the mixture of aqueous saturated NH4Cl solution and 28% 
aqueous NH3 solution (1:1) was added and the solution was stirred at rt for 30 min. 
The reaction mixture was diluted with EtOAc, washed with brine, and dried over 
MgSO4. The solvent was evaporated and the residue was purified by flash column 
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chromatography on silica gel (hexane/EtOAc, 5:1) to give 12 (5.64 g, 92%) as a 
colorless oil: [a]24D –53.9 (c 1.00, CHCl3); 
1H NMR (CDCl3, 500 MHz; two 
rotamers in a 2:1 ratio) d 1.39 (s, 6H), 1.40 (s, 3H), 1.59 (dd, J = 11.8 Hz, 0.7H), 
1.73 (dt, J = 6.95, 13.1 Hz, 0.3H), 1.89–2.01 (m, 2H), 2.04–2.17 (m, 1H), 3.30 (t, J 
= 8.55 Hz, 0.3H), 3.46 (t, J = 8.05 Hz, 0.7H), 3.59 (d, J = 8.75 Hz, 0.3H), 3.68 (d, J 
= 9.00 Hz, 0.7H), 3.86–3.98 (m, 0.3H), 3.99–4.12 (m, 0.7H), 4.22 (t, J = 6.70 Hz, 
0.7H), 4.33 (t, J = 6.25 Hz, 0.3H), 4.57–4.61 (m, 2H), 4.95–5.09 (m, 2H), 5.67–
5.78 (m, 1H), 7.22–7.28 (m, 1H), 7.30 (s, 4H); 13C NMR (CDCl3, 125 MHz; 
rotamer 1/rotamer 2) d 25.3/26.1, 28.32/28.35 (3C), 29.6/28.5, 56.6/56.7, 57.7/59.2, 
59.8/60.6, 69.9/70.5, 77.3/71.6, 79.3/79.1, 113.3/113.8, 127.3/127.5 (2C), 
128.2/128.3 (2C), 138.0/138.2, 138.8/138.5, 154.1/153.5; IR (CHCl3) umax 2975, 
1693, 1385, 1174 (cm-1); MS (FAB) m/z 318 ([M+1]+, 34), 262 (60), 218 (77), 57 
(50); HRMS (FAB) calcd for C19H28NO3 318.2069 ([M+H]





To a solution of 12 (5.00 g, 15.7 mmol) in CH2Cl2/MeCN/H2O (2:2:3, 150 mL) 
were added NaIO4 (13.4 g, 63.0 mmol) and RuCl·H2O (66 mg, 0.314 mmol) at rt. 
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The reaction was vigorously stirred at rt for 2 h, and then diluted with water and 
extracted with CH2Cl2 twice. The organic extracts were dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (CH2Cl2/MeOH, 15:1) to give the known acid 8
2 





To a solution of 8 (2.67 g, 7.98 mmol) and the allylic alcohol 13 (2.58 g, 7.26 
mmol) in CH2Cl2 (35 mL) was added DMAP (97.2 mg, 0.73 mmol) and DCC (2.00 
g, 8.70 mmol) at 0 °C. The reaction mixture was stirred at rt for 2 h and then 
diluted with water. The resulting mixture was extracted with CH2Cl2 twice. The 
combined organic layers were washed with water, dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 10:1) to give the known ester 8 (4.30 




IV-1-2. Claisen rearrangement of allyl ester 7. 
 
To a solution of LiHMDS (20.8 mL, 20.8 mmol, 1.0 M solution in THF) in 
anhydrous THF (100 mL), at –78 °C under N2 atmosphere, was added dropwise a 
solution of 7 (4.00 g, 5.95 mmol) in anhydrous THF (20 mL). The reaction mixture 
was warmed to rt and stirred for 1 day. The reaction was quenched with aqueous 
saturated NH4Cl solution and extracted with EtOAc twice. The combined organic 
layers were washed with brine, dried over Na2SO4, and concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc, 6:1, 1% AcOH) to give the known  6a (3.27 g, 82%) as 
a colorless oil and a minor isomer 6c (327 mg, 8.2%) as a colorless oil. The ratio of 









IV-2. Derivatization of 6c to the bicyclic compound 15 
 
Synthesis of S6. 
 
The bicyclic compound 15 was prepared in a six-step sequence starting from 
Claisene minor isomer 6c. Deprotection of the methylated silyl ether 14, followed 
by mesylation of the resultant alcohol yielded the mesylated product S2 in 92% 
yield for 2 steps. The obtained product was subjected to a Boc-deprotection and 
cyclization. Resultant bicyclic product was reduced with LiAlH4 to give the 
corresponding primary alcohol. To this end, the hydroxyl group was protected as 
acetyl group. Stereochemistry of the resultant acetylated bycyclic product 15 was 






butyldiphenylsilyloxy) hex-1-en-3-yl)pyrrolidine-1,2-dicarboxylate (14). 
 
To a solution of 6c (300 mg, 0.446 mmol) in acetone (3 mL) was added K2CO3 
(48.0 mg, 0.491 mmol) at rt. After stirring the mixture for 1 h, methyl iodide (30.0 
mL, 0.491 mmol) was added dropwise. The resulting mixture was heated under 
reflux for 12 h and then cooled to rt. After the white residue had been filtered off, 
the filtrate was concentrated under reduced pressure. Purification of the resulting 
residue by flash column chromatography on silica gel (hexane/EtOAc, 4:1) gave 
the methyl ester 14 (284 mg, 93%) as a colorless oil: [a]24D –14.5 (c 0.41, CHCl3); 
1H NMR (CDCl3, 500 MHz; two rotamers in a 3:2 ratio) δ 1.01 (s, 9H), 1.12–1.26 
(m, 1H), 1.35 (s, 9H), 1.44–1.69 (m, 3H), 1.81–1.95 (m, 2H), 2.01–2.15 (m, 2H), 
2.95 (t, J = 9.30 Hz, 0.6H), 3.06 (m, 0.4H), 3.30 (m, 0.4H), 3.36 (t, J = 8.30 Hz, 
0.6H), 3.55–3.62 (m, 3H), 3.63 (s, 3H), 4.14 (br s, 0.4H), 4.29 (m, 0.6H), 4.39–
4.51 (m, 2H), 5.03–5.12 (m, 2H), 5.59–5.71 (m, 1H), 7.27–7.42 (m, 11H), 7.61–
7.66 (m, 4H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 19.2, 24.1/24.8, 
26.8 (3C), 28.2 (3C), 30.8, 32.6, 47.0/47.3, 51.7, 59.1/59.3, 64.3, 71.2/71.3, 71.7, 
72.4, 73.0, 79.8, 80.3, 117.4 (2C), 127.4 (2C), 127.5 (4C), 128.2 (2C), 129.4 (2C), 
134.0, 135.5 (4C), 138.4, 138.5, 154.1, 174.4; IR (CHCl3) umax 2954, 2857, 2859, 
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1744, 1698, 1376, 1109, 702 (cm-1); MS (FAB) (m/z) 686 ([M+1]+, 3), 586 (30), 
248 (35), 91 (100), 57 (35); HRMS (FAB) calcd for C41H56NO6Si ([M+H]
+) 





To a solution of 14 (270 mg, 0.393 mmol) in THF (3 mL) was added TBAF 
(0.982 mL, 0.982 mmol, 1.0 M solution in THF). The solution was stirred for 2 h at 
rt, and then the reaction mixture was quenched with aqueous saturated NH4Cl and 
extracted with EtOAc twice. The combined organic layers were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 1:1) to afford alcohol S1 
(172 mg, 98%) as a colorless oil: [a]24D –57.3 (c 0.37, CHCl3); 
1H NMR (CDCl3, 
400 MHz; two rotamers in a 3:2 ratio) δ 1.11–1.22 (m, 1H), 1.40 (s, 9H), 1.49–1.66 
(m, 3H), 1.82–1.91 (m, 1H), 1.92–2.01 (m, 1H), 2.03–2.26 (m, 2H), 2.97 (br s, 
0.4H), 3.26 (br t, J = 9.1 Hz, 0.4H), 3.31 (br t, J = 8.7 Hz, 0.6H), 3.44–3.59 (m, 
2.6H), 3.6 (br s, 1H), 3.65 (s, 3H), 4.13 (br s, 0.6H), 4.30 (br s, 0.4H), 4.47–4.57 
(m, 2H), 5.02–5.12 (m, 2H), 5.58–5.72 (m, 1H), 7.27–7.36 (m, 5H); 13C NMR 
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(CDCl3, 75 MHz; rotamer 1/rotamer 2) δ 22.8, 23.8, 24.9/25.1, 28.3/28.6 (3C), 
30.7/30.9, 33.0, 44.7, 47.4, 51.9, 59.0/59.5, 60.8, 62.8, 71.1/71.4, 73.1, 80.5, 117.8, 
127.5/127.7 (2C), 128.4 (2C), 138.2/138.5, 154.2/155.1, 174.2; IR (CHCl3) umax 
3466, 2951, 1742, 1697, 1455, 1378, 1256, 1167 (cm-1); MS (FAB) m/z 448 
([M+1]+, 10), 348 (75), 248 (30), 91 (100); HRMS (FAB) calcd for C25H37NO6 





To a solution of S1 (150 mg, 0.335 mmol) in CH2Cl2 (3 mL) was added Et3N 
(90.0 mL, 0.670 mmol), MsCl (40.0 mL, 0.502 mmol) at 0 °C. After being stirred 
for 2 h at rt, the reaction was quenched with brine at 0 °C and then the mixture was 
extracted with CH2Cl2 twice. The combined organic layers were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 2:1) to give S2 (165 mg, 
94%) as a light yellow oil: [a]24D –20.9 (c 0.42, CHCl3); 
1H NMR (CDCl3, 400 
MHz; two rotamers in a 1:1 ratio) δ 1.16–1.28 (m, 1H), 1.40 (s, 9H), 1.47–1.62 (m, 
2H), 1.71–1.81 (m, 1H), 1.82–1.96 (m, 2H), 2.03–2.22 (m, 2H), 2.86–2.93 (m, 3H), 
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2.94–3.01 (m, 0.5H), 3.02–3.12 (m, 0.5H), 3.30–3.38 (m, 0.5H), 3.44–3.52 (m, 
0.5H), 3.53–3.62 (m, 1H), 3.64 (s, 3H), 4.05–4.19 (m, 2.5H), 4.3 (br s, 0.5H), 
4.47–4.57 (m, 2H), 5.05–5.16 (m, 2H), 5.57–5.75 (m, 1H), 7.27–7.37 (m, 5H); 13C 
NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 24.0/24.3, 25.0/25.4, 27.1/27.5, 
28.3 (3C), 31.8, 33.2, 37.3, 47.0/47.7, 51.9, 59.4/59.7, 70.0/70.4, 71.5/71.6, 72.3, 
73.1, 80.1/80.6, 118.0, 127.5 (2C), 128.4 (2C), 138.1, 138.3/138.5, 154.2/154.6, 
174.1/174.2; IR (CHCl3) umax 2973, 1741, 1695, 1455, 1364, 1237, 1175 (cm
-1); 
MS (FAB) m/z 548 ([M+23]+, 5), 426 (40), 248 (20), 91 (100); HRMS (FAB) calcd 
for C26H39NNaO8S 548.2294 ([M+Na]





To a solution of S2 (140 mg, 0.266 mmol) in CH2Cl2 (2 mL) was added TFA (0.5 
mL) at 0 °C. After being stirred for 2 h at rt, the mixture was evaporated to dryness 
and the residue was dissolved in MeCN (2 mL). To this solution was added Et3N 
(0.4 mL) and stirred at rt for 16 h. The mixture was concentrated under reduced 
pressure and purified by flash chromatography on silica gel (hexane/EtOAc, 2:1) to 
give S3 (77.0 mg, 88%) as a colorless oil: [a]24D –56.8 (c 0.37, CHCl3); 
1H NMR 
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(CDCl3, 500 MHz) δ 1.30–1.40 (m, 1H), 1.40–1.46 (m, 1H), 1.47–1.52 (m, 1H), 
1.52 (s, 1H), 1.54–1.61 (m, 2H), 1.61–1.67 (m, 1H), 1.68–1.76 (m, 1H), 1.79–1.89 
(m, 1H), 2.84 (dd, J = 3.25, 11.7 Hz, 1H), 2.87–2.92 (m, 1H), 2.97 (dd, J = 5.20, 
11.4 Hz, 1H), 3.21 (dd, J = 6.35, 9.20 Hz, 1H), 3.44 (dd, J = 4.60, 9.15 Hz, 1H), 
3.67 (s, 3H), 4.52 (dd, J = 12.4, 13.4 Hz, 2H), 5.01–5.11 (m, 2H), 6.11 (td, J = 9.85, 
17.3 Hz, 1H), 7.27–7.34 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 20.6, 25.3, 29.5, 
32.2, 42.8, 44.8, 51.1, 72.1, 73.1, 74.2, 116.1, 127.4 (2C), 128.3 (2C), 138.7, 138.9, 
176.4; IR (CHCl3) umax 2934, 2856, 1728, 1496, 1453, 1231, 1169, 1100 (cm
-1); 
MS (CI) m/z 330 ([M+1]+, 100), 270 (85), 208 (55); HRMS (FAB) calcd for 
C20H27NO3 330.2069 ([M+H]





To a solution of ester S3 (60.0 mg, 0.182 mmol) in anhydrous THF (1.5 mL) at –
78 °C was slowly added LiAlH4 (0.455 mL, 0.455 mmol, 1.0 M solution in THF). 
The reaction mixture was allowed to warm to rt for 1 h. H2O (90 mL), 10% aqueous 
NaOH solution (90 mL) and H2O (270 mL) were added to the mixture in that order. 
The resulting mixture was filtered through a glass funnel packed with Celite. The 
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filtrate was concentrated under reduced pressure, and purified by flash column 
chromatography on silica gel (CH2Cl2/MeOH/28% aqueous NH3, 100:10:1) to give 
alcohol S4 (52.0 mg, 96%) as a colorless oil: [a]24D +3.58 (c 0.37, CHCl3); 
1H 
NMR (CDCl3, 400 MHz) d 1.21–1.36 (m, 2H), 1.41–1.53 (m, 1H), 1.54–1.76 (m, 
4H), 1.78–1.89 (m, 1H), 2.47 (dt, J = 2.88, 11.1 Hz, 1H), 2.63 (dt, J = 3.48, 9.20 
Hz, 1H), 2.78–2.86 (m, 1H), 3.35–3.44 (m, 3H), 3.48 (d, J = 10.8 Hz, 1H), 3.56–
3.63 (m, 1H), 4.51 (s, 2H), 5.01 (dd, J = 1.64, 10.2 Hz, 1H), 5.08 (d, J = 17.1 Hz, 
1H), 5.77 (td, J = 9.56, 17.3 Hz, 1H), 7.27–7.37 (m, 5H); 13C NMR (CDCl3, 100 
MHz) d 23.3, 24.6, 25.9, 26.9, 42.2, 43.3, 59.9, 61.0, 68.5, 71.1, 73.2, 116.3, 127.6, 
127.7 (2C), 128.4 (2C), 138.2, 140.0; IR (CHCl3) umax 3450, 2923, 2853, 1737, 
1246 (cm-1); MS (FAB) m/z 302 ([M+1]+, 100), 270 (26), 91 (45); HRMS (FAB) 
calcd for C19H27NO2 302.2120 ([M+H]





To a solution of alcohol S4 (30.0 mg, 99.0 mmol) in CH2Cl2 (1 mL) was added 
Et3N (41.0 mL, 0.297 mmol), DMAP (2.44 mg, 20.0 mmol), and Ac2O (18.6 mL, 
0.198 mmol) at 0 °C. After being stirred for 3 h at rt, the reaction mixture was 
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quenched with brine at 0 °C and then the mixture was extracted with CH2Cl2 twice. 
The combined organic layers were washed with saturated NH4Cl and brine, dried 
over Na2SO4, and concentrated under reduced pressure. The residue was purified 
by flash chromatography on silica gel (CH2Cl2/MeOH, 15:1) to give 15 (28.0 mg, 
85%) as a colorless oil: 1H NMR (CDCl3, 400 MHz) d 1.21–1.31 (m, 1H), 1.40–
1.59 (m, 4H), 1.61–1.74 (m, 1H), 1.83–1.99 (m, 2H), 2.07 (s, 1H), 2.37–2.44 (m, 
1H), 2.69 (dt, J = 3.04, 12.0 Hz, 1H), 2.94 (dd, J = 4.48, 11.5 Hz, 1H), 3.01–3.07 
(m, 1H), 3.26 (dd, J = 5.96, 9.28 Hz, 1H), 3.48 (dd, J = 4.92, 9.24 Hz, 1H), 4.02 (d, 
J = 11.1 Hz, 1H), 4.39 (d, J = 11.1 Hz, 1H), 4.52 (s, 2H), 4.99 (s, 1H), 5.03 (dd, J = 
1.96, 8.84 Hz, 1H), 6.23 (td, J = 10.2, 17.0 Hz, 1H), 7.28–7.38 (m, 5H); 13C NMR 
(CDCl3, 100 MHz) d 21.0, 21.1, 25.4, 27.3, 29.2, 29.6, 41.4, 43.3, 59.4, 61.1, 63.8, 
73.2, 74.7, 114.9, 127.4 (2C), 128.3 (2C), 138.6, 140.2, 171.3; IR (CHCl3) umax 
2925, 2854, 1740, 1235 (cm-1); MS (FAB) m/z 344 ([M+1]+, 100), 270 (26), 91 
(45); HRMS (FAB) calcd for C21H29NO3 344.2147 ([M+H]
+), found 344.2143. The 












To a solution of aldehyde 26 (200 mg, 0.481 mmol) in anhydrous THF (5 mL) 
was added a solution of hexylmagnesium bromide (360 mL, 0.721 mmol, 2.0 M 
solution in Et2O) at –78 °C under N2 atmosphere. The reaction mixture was 
warmed to rt and stirred for 1 h. The reaction was quenched with aqueous saturated 
NH4Cl solution and extracted with CH2Cl2 twice. The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and concentrated under 
reduced pressure. The resulting residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 5:1) to give 31 (220 mg, 92%) as a 
light yellow oil: 1H NMR (CDCl3, 400 MHz; two rotamers in a 3:1 ratio) δ 0.81–
1.01 (m, 4H), 1.13–1.31 (m, 11H), 1.37 and 1.45 (each s, total 9H in a 3:1 ratio), 
1.52–1.69 (m, 8H), 1.71– 1.89 (m, 3H), 1.96–2.07 (m, 1H), 2.13–2.43 (m, 2H), 
2.52–2.69 (m, 1H), 3.27 (dt, J = 3.68, 8.80 Hz, 2/3H), 3.4 (t, J = 8.40 Hz, 1/3H), 
3.45–3.64 (m, 2H), 4.06 (br s, 2/3H), 4.21 (br s, 1/3H), 4.45–4.59  (m, 2H), 7.26–
7.37 (m, 5H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 14.1, 22.6, 
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24.0/24.1/24.2, 25.0, 25.5/25.6/25.7/25.8, 26.1/26.2/26.3/26.8, 28.5/28.6/28.8 (3C), 
29.3/29.4/29.7, 30.6/30.7, 31.8, 33.9, 35.2/35.9, 37.1/37.3/37.6, 38.3/38.4/38.5, 
39.1/39.9, 59.0/59.1/59.2, 68.0/68.6/68.7, 70.0/70.7, 71.2/71.3, 72.8/73.01/73.04, 
78.8/79.1/79.4, 127.3/127.4 (2C), 127.54/127.56, 128.2/128.3 (2C), 
138.3/138.4/138.7, 153.0/153.5/153.9; IR (CHCl3) umax 3470, 2928, 2856, 1737, 
1676, 1366 (cm-1); MS (FAB) m/z 502 ([M+1]+, 20), 402 (50), 280 (55), 91 (100); 
HRMS (FAB) calcd for C31H52NO4 502.3896 ([M+H]









31 32  
To a solution of 31 (200 mg, 0.398 mmol) in CH2Cl2 (2 mL) at 0 °C was added 
NaHCO3 (100 mg, 1.19 mmol) and Dess-Martin periodinane (336 mg, 0.796 
mmol). After stirring for 30 min at 0 °C, the reaction mixture was quenched upon 
the addition of isopropyl alcohol (100 mL) and then warmed to rt. The resulting 
mixture was filtered through Celite and the filtrate was concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 6:1) to afford the ketone 32 (183 mg, 93%) as a colorless oil: 
[a]24D –19.3 (c 0.5, CHCl3); 
1H NMR (CDCl3, 400 MHz; two rotamers in a 3:1 
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ratio) δ 0.81–1.01 (m, 4H), 1.05–1.31 (m, 10H), 1.37 and 1.45 (each s, total 9H in a 
3:1 ratio), 1.49–1.75 (m, 9H), 1.76–1.88 (m, 2H), 1.94–2.06 (m, 1H), 2.13–2.52 (m, 
6H), 3.27 (t, J = 8.68 Hz, 2/3H), 3.41 (t, J = 8.24 Hz, 1/3H), 3.49  (dd, J = 3.16, 
8.88 Hz, 2/3H), 3.59  (dd, J = 2.81, 8.84 Hz, 1/3H), 4.02–4.11 (m, 2/3H), 4.17–
4.24 (m, 1/3H), 4.43–4.59  (m, 2H), 7.26–7.37 (m, 5H); 13C NMR (CDCl3, 100 
MHz; rotamer 1/rotamer 2) δ 14.0, 22.4, 23.9/24.0, 24.5, 25.6/25.7, 26.1/26.2, 
28.5/28.6 (3C), 28.9, 29.5/29.6, 31.6/31.7, 32.2, 38.1, 39.0/39.7, 41.3/41.4, 
42.7/42.8, 58.9/59.2, 67.8/68.4, 70.7/71.3, 73.0, 78.8/79.4, 127.3, 127.4/127.5 (2C), 
128.2/128.3 (2C), 138.4/138.7, 152.8/153.8, 211.3/211.9; IR (CHCl3) umax 2928, 
2857, 1713, 1691, 1374 (cm-1); MS (FAB) m/z 500 ([M+1]+, 20), 400 (100), 278 







To a solution of 33 (30.0 mg, 60.0 mmol) in dry CH2Cl2 (0.5 mL) was added TFA 
(0.3 mL) at 0 °C. The reaction mixture was stirred at rt for 1 h, and the solvent and 
reagent were removed under reduced pressure. The resulting residue 30 was 
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dissolved in MeOH (0.5 mL). To this solution was added NaCNBH3 (13.1 mg, 
0.210 mmol) at –78 °C. The reaction mixture was stirred for 1 h at the same 
temperature and then warmed to rt. The reaction mixture was quenched with 
aqueous saturated NH4Cl solution. It was poured into brine, and extracted with 
EtOAc twice. The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. The resulting residue was filtered through a 
short pad of silica gel using organic solvent (CH2Cl2/MeOH/28% aqueous NH3, 
100:10:1), and the filtrate was evaporated to dryness in vacuo to give the known 




To a solution of 33 (30.0 mg, 60.0 mmol) in dry CH2Cl2 (0.5 mL) was added TFA 
(0.3 mL) at 0 °C. The reaction mixture was stirred at rt for 1 h, and the solvent and 
reagent were removed under reduced pressure. The resulting residue 30 was 
dissolved in THF (0.5 mL). To this solution was added L-Selectiride (0.210 mL, 
0.210 mmol, 1.0 M solution in THF) at –78 °C. The reaction mixture was stirred 
for 2 h at the same temperature and then quenched with aqueous saturated NH4Cl 
solution. It was poured into brine, and extracted with EtOAc twice. The combined 
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organic layers were dried over Na2SO4 and concentrated under reduced pressure. 
The resulting residue was filtered through a short pad of silica gel using organic 
solvent (CH2Cl2/MeOH/28% aqueous NH3, 100:10:1), and the filtrate was 
evaporated to dryness in vacuo to give the known 35 as a diastereomer (ca. ~1:1).  
 
IV-4. Synthesis of model system substrate 37a–c and 
reductive amination product 39a–c 
 
IV-4-1. Synthesis of 49a. 
 
The reductive amination substrate 37a was prepared in a six-step sequence 
starting from commercially available tert-butyl 2-oxopyrrolidine-1-carboxylate S5. 
The 1-pentene magnesium bromide addition of ketone S5 was followed with 
NaBH4 reduction, giving the alcohol S7. Treatment of S7 with BF3·OEt2 in the 
presence of trimethyl orthoacetate resulted in the cyclization product S8 in 72% 
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yield. Next, terminal double bond S8 was converted into the corresponding 
aldehyde by ozonolysis. The resultant aldehyde S9 was subjected to Grignard 
addtion to give the S10. Finally, compound S10 was converted to 37a by DMP 
oxidation of its secondary alcohol.  
 





S5 S6  
To a solution of magnesium turnings (1.17 g, 48.3 mmol) in THF (40 mL) was 
added dropwise 5-bromopent-1-ene (0.860 mL, 7.24 mmol) at rt, and the mixture 
was stirred for 20 min. An additional portion of 5-bromopent-1-ene (2.00 mL, 16.8 
mmol) was added dropwise, and the mixture was stirred at rt for 1 h. The resulting 
mixture was then transferred via cannula to a stirred solution of tert-butyl 2-
oxopyrrolidine-1-carboxylate S5 (3.00 g, 16.1 mmol) in THF (50 mL) at –78 °C, 
and stirring was continued at –78 °C for 1.5 h. Isopropyl alcohol (4 mL) was added, 
and the cooling bath was removed. The mixture was quenched with saturated 
aqueous NaHCO3 solution. The aqueous layer was extracted with EtOAc twice, 
and the combined organic layers were washed with brine, dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (hexanes/EtOAc, 1:3) to give S6 (3.83 g, 93%) as a 
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clear oil: 1H NMR (CDCl3, 400 MHz) d 1.40 (s. 9H), 1.64 (qd, J = 7.36 Hz, 2H), 
1.72 (qd, J = 7.01 Hz, 2H), 2.02 (dd, J = 7.04, 14.2 Hz, 2H), 2.39 (td, J = 7.12, 12.0 
Hz, 4H), 3.08 (t, J = 6.72 Hz, 2H), 4.54 (br s, 1H), 4.92–5.02 (m, 2H), 5.73 (tdd, J 
= 6.72, 10.2, 16.9 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d 22.7, 23.9, 28.3 (3C), 
33.0, 39.8, 40.1, 41.9, 79.2, 115.2, 137.8, 155.9, 210.4; IR (CHCl3) umax 3370, 2977, 
2931, 1696, 1517, 1167 (cm-1); MS (FAB) m/z 256 ([M+1]+, 20), 200 (60), 156 
(35); HRMS (FAB) calcd for C14H26NO3 256.1913 ([M+H]
+), found 256.1916. 
 
tert-butyl 4-hydroxynon-8-enylcarbamate (S7). 
 
To a solution of S6 (3.0 g, 11.8 mmol) in MeOH (30 mL) was added NaBH4 (550 
mg, 14.1 mmol) at 0 °C. The reaction mixture was warmed up to rt and stirred for 
30 min. The reaction was quenched with aqueous saturated NH4Cl solution and 
then the mixture was extracted with EtOAc twice. The combined organic layers 
were washed with brine, dried over MgSO4, and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 1:1) to give compound S7 (2.72 g, 90%) as a colorless oil: 1H 
NMR (CDCl3, 300 MHz) d 1.41 (s. 9H), 1.42–1.65 (m, 9H), 2.01–2.10 (m, 2H), 
3.02–3.18 (m, 2H), 3.59 (pentet, J = 3.66 Hz, 1H), 4.58 (br s, 1H), 4.91–5.02 (m, 
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2H), 5.77 (tdd, J = 6.78, 10.2, 16.8 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d 24.8, 
26.3, 28.4 (3C), 33.6, 34.3, 37.0, 40.5, 71.4, 79.1, 114.6, 138.6, 156.0; IR (CHCl3) 
umax 3352, 2976, 2864, 1692, 1529, 1173 (cm
-1); MS (FAB) m/z 258 ([M+1]+, 65), 




tert-butyl 2-(pent-4-enyl)pyrrolidine-1-carboxylate (S8). 
 
To a solution of S7 (2.60 g, 10.1 mmol), trimethyl orthoacetate (1.92 mL, 15.1 
mmol), in CH2Cl2 (100 mL) was added BF3·OEt2 (0.620 mL, 5.05 mmol) at 0 °C. 
The reaction mixture was stirred at rt for 45 min and quenched with aqueous 
saturated NaHCO3 solution, extracted with EtOAc twice. The combined organic 
layers were washed with brine, dried over Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc, 12:1) to give S8 (1.73 g, 72%) as a colorless oil: 1H 
NMR (CDCl3, 400 MHz) d 1.21–1.39 (m, 3H), 1.43 (s. 9H), 1.56–1.67 (m, 1H), 
1.72–1.95 (m, 3H), 1.97–2.12 (m, 2H), 3.22–3.43 (m, 2H), 3.69 (br s, 1H), 4.88–
5.02 (m, 2H), 5.78 (tdd, J = 6.64, 10.2, 16.9 Hz, 1H); 13C NMR (CDCl3, 75MHz) d 
23.1, 25.6, 28.5 (3C), 30.6, 33.7, 34.1, 46.1, 57.1, 78.8, 114.3, 138.7, 154.6; IR 
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(CHCl3) umax 2973, 2873, 1697, 1394, 1172 (cm
-1); MS (FAB) m/z 238 ([M+1]+, 




tert-butyl 2-(4-oxobutyl)pyrrolidine-1-carboxylate (S9). 
NBoc NBoc
O
S8 S9  
A solution of S8 (1.60 g, 6.71 mmol) in a mixture CH2Cl2 (20 ml) and MeOH (5 
ml) was cooled to –78 °C. Ozone was bubbled through the solution until a blue 
color persisted. After TLC indicated the absence of starting material, the ozone 
inlet tube was replaced with nitrogen and nitrogen was bubbled through the 
solution for 20 min to remove any excess ozone. Triphenylphosphine (2.63 g, 10.1 
mmol) was added in one portion, the cooling bath was removed and the mixture 
was stirred for 3 h at rt. The solution was concentrated and the residue was purified 
by flash column chromatography on silica gel (hexane/EtOAc, 2:1) to afford the 
aldehyde S9 (1.36 g, 80%) as a colorless oil : 1H NMR (CDCl3, 300 MHz) d 1.21–
1.39 (m, 3H), 1.43 (s. 9H), 1.51–1.99 (m, 5H), 2.41–2.51 (m, 2H), 3.23–3.42 (m, 




tert-butyl 2-(4-hydroxydecyl)pyrrolidine-1-carboxylate (S10). 
 
To a solution of aldehyde S9 (1.30 g, 5.11 mmol) in anhydrous THF (20 mL) was 
added a solution of hexylmagnesium bromide (3.83 mL, 7.66 mmol, 2.0 M solution 
in Et2O) at –78 °C under N2 atmosphere. The reaction mixture was was warmed to 
rt and stirred for 1 h. The reaction was quenched with aqueous saturated NH4Cl 
solution and extracted with CH2Cl2 twice. The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc, 2.5:1) to give S10 (1.33 g, 80%) as a light yellow oil: 1H 
NMR (CDCl3, 400 MHz; two diastereomer in a 1:1 ratio) δ 0.84 (t, J = 6.08 Hz, 
3H), 1.17–1.31 (m, 9H), 1.32–1.51 (m, 12H), 1.54–1.92 (m, 9H), 3.21–3.42 (m, 
2H), 3.47–3.61 (m, 1H), 3.68 (br s, 0.5H), 3.76 (br s, 0.5H); 13C NMR (CDCl3, 75 
MHz; major/minor diastereomer) δ 14.0/14.1, 22.3/22.5, 23.0, 23.6, 25.5/25.6, 
28.3/28.5 (3C), 29.3, 30.0/30.5, 31.8, 34.2/34.6, 37.4/37.6, 46.0/45.3, 57.1, 71.6, 
71.8, 78.9, 154.6; IR (CHCl3) umax 3442, 2928, 2857, 1696, 1401, 1171 (cm
-1); MS 
(FAB) m/z 328 ([M+1]+, 45), 272 (40), 254 (85), 226 (100), 114 (80); HRMS 
(FAB) calcd for C19H38NO3 328.2852 ([M+H]
+), found 328.2849. 
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tert-butyl 2-(4-oxodecyl)pyrrolidine-1-carboxylate (37a). 
 
To a solution of S10 (1.30 g, 3.96 mmol) in CH2Cl2 (15 mL) at 0 °C was added 
NaHCO3 (665 mg, 7.92 mmol) and Dess–Martin periodinane (2.51 g, 5.94 mmol). 
After stirring for 30 min at 0 °C, the reaction mixture was quenched upon the 
addition of isopropyl alcohol (1 mL) and then warmed to rt. The resulting mixture 
was filtered through Celite and the filtrate was concentrated under reduced pressure. 
The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 3:1) to afford the ketone 37a (1.16 g, 90%) as a colorless oil: 1H 
NMR (CDCl3, 400 MHz) δ 0.79 (t, J = 6.16 Hz, 3H), 1.14–1.28 (m, 7H), 1.37 (s, 
9H), 1.42–1.54 (m, 5H), 1.55–1.62 (m, 1H), 1.66–1.89 (m, 3H), 2.24–2.41 (m, 4H), 
3.15–3.35 (m, 2H), 3.64 (br s, 1H); 13C NMR (CDCl3, 75 MHz) δ 13.8, 20.3, 22.3, 
23.0, 23.6, 28.4 (3C), 28.7, 29.6/30.4, 31.4, 33.4/34.1, 42.4, 42.6, 45.9/46.2, 56.8, 
78.7, 154.4, 210.7; IR (CHCl3) umax 2931, 2871, 1694, 1395, 1171 (cm
-1); MS 
(FAB) m/z 326 ([M+1]+, 20), 270 (15), 226 (100), 224 (45); HRMS (FAB) calcd for 
C19H36NO3 326.2695 ([M+H]





IV-4-2. Synthesis of 37b and 37c. 
 
The reductive amination substrate 37b and 37c were prepared in each three-step, 
seven-step sequence starting from known compound S11. Towards the 37b, 
terminal double bond S12 was converted into the corresponding aldehyde by 
ozonolysis. The resultant aldehyde S12 was subected to a wittig reaction to give 
a,b-unsaturated carbonyl compound S13 in 80% yield. Catalytic hydrogenation of 
S14 over Pd/C resulted in the reduction of double bond to afford the redcutive 
amination substrate 37b (90%). Next towards the 37c, the obtainde 37b was 
subjected to acetal protection and LiAlH4 reduction to give the S15. TBDPS 
protection of S15, followed by acetal deprotection of S16 successfully provided the 





1-tert-butyl 2-methyl 2-(2-oxoethyl)pyrrolidine-1,2-dicarboxylate (S12). 
 
A solution of S11 (4.50 g, 16.7 mmol) in a mixture CH2Cl2 (40 mL) and MeOH 
(10 mL) was cooled to –78 °C. Ozone was bubbled through the solution until a 
blue color persisted. After TLC indicated the absence of starting material, the 
ozone inlet tube was replaced with nitrogen and nitrogen was bubbled through the 
solution for 20 min to remove any excess ozone. Triphenylphosphine (6.57 g, 25.1 
mmol) was added in one portion, the cooling bath was removed and the mixture 
was stirred for 3 h at rt. The solution was concentrated and the residue was purified 
by flash column chromatography on silica gel (hexane/EtOAc, 4:1) to afford the 
aldehyde S12 (3.85 g, 85%) as a colorless oil: 1H NMR (CDCl3, 400 MHz; two 
rotamers in a 1:1 ratio) δ 1.34 (s, 4.5H), 1.36 (s, 4.5 H), 1.77–1.98 (m, 2H), 2.03–
2.26 (m, 2H), 2.71 (d, J = 15.3 Hz, 0.5H), 2.86–3.04 (m, 1.5H), 3.35–3.45 (m, 1H), 
3.46–3.55 (m, 0.5H), 3.37–3.64 (m, 0.5H), 3.67 and 3.68  (each s, total 3H in a 
1:1 ratio), 9.73 (s, 1H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 
22.4/23.0, 28.1/28.2 (3C), 36.9/38.1, 47.7, 48.4/49.0, 52.4, 65.6/66.1, 80.1/80.9, 




(E)-1-tert-butyl 2-methyl 2-(4-oxopent-2-enyl)pyrrolidine-1,2-dicarboxylate 
(S13). 
 
To a solution of aldehyde S12 (3.70 g, 13.6 mmol) in CH2Cl2 (40 mL) was added 
(acetyl methylene)-triphenylphosphorane (12.9 g, 40.8 mmol) at rt. The reaction 
mixture was heated to reflux for 1 h and then cooled to rt. The reaction mixture was 
filtered through Celite and the filtrate was concentrated under reduced pressure. 
The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 3:1) to give S13 (3.38 g, 80%) as a colorless oil: 1H NMR (CDCl3, 
400 MHz; two rotamers in a 1:1 ratio) δ 1.32 (s, 4.5H), 1.34 (s, 4.5H), 1.64–1.73 
(m, 1H), 1.78–2.07 (m, 3.5H), 2.14 (s, 3H), 2.68 (dd, J = 8.64, 14.5 Hz, 0.5H), 2.75 
(dd, J = 7.96, 14.5 Hz, 0.5H), 2.88 (dd, J = 7.12, 14.4 Hz, 0.5H), 3.25–3.36 (m, 
1H), 3.48 (td, J = 7.12, 10.4 Hz, 0.5H), 3.56–3.62 (m, 0.5H), 3.62 and 3.64 (each s, 
total 3H in a 1:1 ratio), 6.03 (dd, J = 11.4, 15.8 Hz, 1H), 6.68 (hepet, J = 7.80 Hz, 
1H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 22.4/22.9, 26.8/26.9, 
28.12/28.14 (3C), 36.1/37.1, 37.8/38.6, 48.2, 52.1, 66.7/67.2, 79.7/80.3, 
133.8/134.2, 142.4/143.2, 153.2/153.9, 173.9/174.2, 197.7/198.1; IR (CHCl3) umax 
2977, 2882, 1743, 1697, 1390, 1166 (cm-1); MS (FAB) m/z 312 ([M+1]+, 40), 256 





1-tert-butyl 2-methyl 2-(4-oxopentyl)pyrrolidine-1,2-dicarboxylate (37b). 
 
To a solution of S13 (3.30 g, 10.5 mmol) in MeOH (30 mL) was added 10% Pd/C 
(1.50 g, 50% wt. of S13). The flask was evacuated, filled with H2, and stirred at rt 
for 12 h. The mixture was then filtered through Celite. The filtrate was 
concentrated and the residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc, 3:1) to give 37b (2.95 g, 90%) as a colorless oil: 1H 
NMR (CDCl3, 500 MHz; two rotamers in a 3:2 ratio) δ 1.28 and 1.32 (each s, total 
9H in a 3:2 ratio), 1.35–1.56 (m, 2H), 1.66–1.83 (m, 3H), 1.90–2.00 (m, 2.4H), 
2.01 and 2.02 (each s, total 3H in a 3:2 ratio), 2.10 (dt, J = 4.80, 13.4 Hz, 0.6H), 
2.34 (t, J = 7.15 Hz, 2H), 3.25–3.33 (m, 1H), 3.45–3.52 (m, 0.6H), 3.56 and 3.57 
(each s, total 3H in a 2:3 ratio), 3.58–3.63 (m, 0.4H); 13C NMR (CDCl3, 125 MHz; 
rotamer 1/ rotamer 2) δ 17.6/17.7, 22.5/22.9, 28.1/28.2 (3C), 29.4/29.7, 33.3/34.4, 
35.8/37.1, 43.3/43.4, 48.3/48.4, 51.8, 67.1/67.6, 79.2/79.7, 153.4/153.9, 
174.8/175.0, 207.8/208.5; IR (CHCl3) umax 2976, 2880, 1741, 1696, 1391, 1164 
(cm-1); MS (FAB) m/z 314 ([M+1]+, 35), 258 (50), 214 (100), 154 (90); HRMS 
(FAB) calcd for C16H28NO5 314.1967 ([M+H]





A mixture of ketone 37b (1.00 g, 3.19 mmol), ethylene glycol (5.57 mL, 100 
mmol) and pyridinium p-toluenesulfonate (160 mg, 0.630 mmol) in dry toluene (40 
mL) was heated to reflux under a Dean-Stark trap for 3 h. The reaction mixture was 
then allowed to cool to rt and the benzene was removed under reduced pressure. 
The residue was diluted with Et2O and washed with aqueous 5% aqueous Na2CO3 
solution. The organic layer was dried over MgSO4 and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 1:1) to give the S14 (1.05 g, 92%) as a colorless oil: 1H NMR 
(CDCl3, 400 MHz; two rotamers in a 3:2 ratio) δ 1.28 (s, 3H), 1.37 and 1.41 (each s, 
total 9H in a 3:2 ratio), 1.29–1.35 (m, 1H), 1.55–1.69 (m, 3H), 1.72–1.93 (m, 3H), 
1.98–2.15 (m, 2.6H), 2.26 (dt. J = 5.01, 13.2 Hz, 0.4H), 3.31–3.43 (m, 1H), 3.54–
3.61 (m, 0.4H), 3.66 (s, 3H), 3.68–3.74 (m, 0.6H), 3.84–3.96 (m, 4H); 13C NMR 
(CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 18.0/18.3, 22.7/23.2, 23.6/23.7, 
28.3/28.4 (3C), 34.1/35.3, 36.0/37.4, 39.1/39.4, 48.5/48.6, 52.0, 64.6, 67.4/69.7, 
79.3/79.8, 109.8/110.0, 153.8, 175.2/175.4; IR (CHCl3) umax 2979, 2879, 1742, 
1697, 1392, 1163 (cm-1); MS (FAB) m/z 358 ([M+1]+, 25), 302 (15), 196 (100), 154 
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(35); HRMS (FAB) calcd for C18H32NO6 358.2230 ([M+H]





To a solution of ester S14 (1.00 g, 2.79 mmol) in anhydrous THF (15 mL) at –
78 °C was slowly added LiAlH4 (3.34 mL, 3.34 mmol, 1.0 M solution in THF). 
The reaction mixture was allowed to warm to rt for 1 h. H2O (1 mL), 10% aqueous 
NaOH solution (1 mL) and H2O (3 mL) were added to the mixture in that order. 
The resulting mixture was filtered through a glass funnel packed with Celite. The 
filtrate was concentrated under reduced pressure, and purified by flash column 
chromatography on silica gel (hexane/EtOAc, 1:1) to give alcohol S15 (836 mg, 
91%) as a colorless oil: 1H NMR (CDCl3, 400 MHz) δ 1.15–1.26 (m, 1H), 1.28 (s, 
3H), 1.41 (s, 9H), 1.47–1.76 (m, 7H), 1.88 (dq, J = 3.44, 10.5 Hz, 2H), 3.31–3.43 
(m, 2H), 3.57–3.64 (m, 2H), 3.85–3.94 (m, 4H), 5.18–5.26 (m, 1H); 13C NMR 
(CDCl3, 100 MHz) δ 19.0, 22.0, 23.6, 28.4 (3C), 32.6, 34.1, 39.3, 48.7, 52.0, 64.5 
(2C), 67.5, 69.3, 109.9, 156.1; IR (CHCl3) umax 3384, 2976, 2879, 1688, 1394, 
1172 (cm-1); MS (FAB) m/z 330 ([M+1]+, 15), 298 (15), 212 (100), 168 (35); 
HRMS (FAB) calcd for C17H32NO5 330.2280 ([M+H]





To a solution of alcohol S15 (820 mg, 2.49 mmol) in DMF (10 mL) were added 
tert-butylchlorodiphenylsilane (2.05 g, 7.47 mmol), imidazole (680 mg, 9.96 
mmol), DMAP (92.0 mg, 0.750 mmol) at rt. The reaction mixture was heated to 
120 °C for 1 h and then cooled to rt. The reaction was quenched with saturated 
aqueous NaHCO3 solution at 0 °C and then extracted with EtOAc twice. The 
combined organic layers were washed with brine, dried over MgSO4, and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 5:1) to give S16 (1.28 g, 91%) as a 
colorless oil: 1H NMR (CDCl3, 400 MHz; two rotamers in a 3:1 ratio) δ 1.02 and 
1.03 (each s, total 9H in a 1:3 ratio), 1.27 and 1.30 (each s, total 9H in a 1:3 ratio), 
1.43 (s, 3H), 1.45–1.52 (m, 1H), 1.53–1.98 (m, 8H), 2.07–2.27 (m, 1H), 3.32–3.59 
(m, 3H), 3.68 (d, J = 9.28 Hz, 2/3H), 3.82–3.94 (m, 4H), 4.13 (d, J = 9.64 Hz, 
1/3H), 7.30–7.44 (m, 6H), 7.58–7.67 (m, 4H); 13C NMR (CDCl3, 100 MHz; 
rotamer 1/rotamer 2) δ 17.8/18.5, 19.2/19.3, 21.8/22.5, 23.5/23.7, 26.81/26.85 (3C), 
28.4/28.5 (3C), 33.6/34.2, 34.4/35.1, 39.2/39.7, 49.3/49.4, 64.5/64.6 (2C), 
65.9/66.6, 66.7/67.8, 78.3/79.1, 127.5/127.6 (4C), 129.4/129.5 (2C), 133.3/133.5 
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(2C), 135.5/135.6 (4C), 153.4/154.1; IR (CHCl3) umax 2958, 2876, 1690, 1391, 
1111 (cm-1); MS (FAB) m/z 358 ([M+1]+, 25), 302 (15), 196 (100), 154 (35); 
HRMS (FAB) calcd for C33H50NO5Si 568.3458 ([M+H]





To a solution of S16 (1.00 g, 1.76 mmol) in MeCN (8 mL) and H2O (2 mL) was 
added pyridinium p-toluenesulfonate (44.2 mg, 0.176 mmol) at 0 °C. The reaction 
mixture was heated to reflux for 1 h and then cooled to rt. The reaction was 
quenched with saturated aqueous NaHCO3 solution at 0 °C and then the mixture 
was extracted with EtOAc twice. The combined organic layers were washed with 
brine, dried over MgSO4, and concentrated under reduced pressure. The residue 
was purified by flash column chromatography on silica gel (hexane/EtOAc, 5:1) to 
give 37c (811 mg, 88%) as a colorless oil: 1H NMR (CDCl3, 400 MHz; two 
rotamers in a 1:1 ratio) δ 1.01 (s, 4.5H), 1.03 (s, 4.5H), 1.27 (s, 4.5H), 1.42 (s, 
4.5H), 1.48–1.93 (m, 7H), 2.07 (s, 1.5H), 2.09  (s, 14.5H), 2.12–2.43 (m, 3H), 
3.34–3.59 (m, 3H), 3.69 (d, J = 9.56 Hz, 0.5H), 4.10 (d, J = 9.60 Hz, 0.5H), 7.31–
7.44 (m, 6H), 7.58–7.67 (m, 4H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 
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2) δ 17.9/19.2, 21.8/22.4, 26.4/26.5 (3C), 28.4/28.5 (3C), 29.9, 33.3/33.6, 34.5, 
39.2/39.7, 43.9, 49.3/49.4, 65.8/66.5, 66.7/67.7, 78.5/79.3, 127.5/127.6 (4C), 
129.5/129.6 (2C), 133.3/133.4, 133.5/133.7, 135.5/135.6 (4C), 153.5/154.0, 
208.5/209.1; IR (CHCl3) umax 2960, 2858, 1690, 1392, 1112 (cm
-1); MS (FAB) m/z 
524 ([M+1]+, 25), 424 (95), 254 (40), 135 (50); HRMS (FAB) calcd for 
C31H46NO4Si 524.3196 ([M+H]
+), found 524.3189. 
 
IV-4-3. Reagent-controlled diastereoselective reductive amination of model 
system. 
 
General Method A: To a solution of 37 in dry CH2Cl2 (0.2 M) was added TFA 
(35% of CH2Cl2) at 0 °C. The reaction mixture was stirred at rt for 1 h, and the 
solvent and reagent were removed under reduced pressure. The resulting residue 38 
was dissolved in corresponding solvent (0.2 M: see Table S1). To this solution was 
added reducing agent (3.5 equiv) at corresponding temperature (see Table S1). The 
reaction mixture was stirred for 1 h at the same temperature and then warmed to rt. 
The reaction mixture was quenched with aqueous saturated NH4Cl solution. It was 
poured into brine, and extracted with EtOAc twice. The combined organic layers 
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were dried over Na2SO4 and concentrated under reduced pressure. Yields and ratio 
were determined by GC analysis of the crude reaction mixture. 
General Method B: To a solution of 37 in dry CH2Cl2 (0.2 M) was added TFA 
(35% of CH2Cl2) at 0 °C. The reaction mixture was stirred for at rt for 1 h, and the 
solvent and reagent were removed under reduced pressure. The resulting residue 38 
was dissolved in anhydrous THF (0.2 M). To this solution was added L-Selectiride 
or Super hydride (3.5 equiv, 1.0 M solution in THF) at –78 °C. The reaction 
mixture was stirred for 2 h at the same temperature and then quenched with 
aqueous saturated NH4Cl solution. It was poured into brine, and extracted with 
EtOAc twice. The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. The resulting residue was filtered through a 
short pad of silica using EtOAc and the filtrate was concentrated under reduced 
pressure. Yields and ratio were determined by GC analysis of the crude reaction 
mixture. 
General Method C: To a solution of 37 in dry CH2Cl2 (0.2 M) was added TFA 
(35% of CH2Cl2) at 0 °C. The reaction mixture was stirred at rt for 1 h, and the 
solvent and reagent were removed under reduced pressure. The resulting residue 38 
was dissolved in MeOH (0.2 M) at rt. To this solution was added 5% Pd/C (50% wt. 
of 38).  The flask was evacuated, filled with H2, and stirred at rt for 6 h. The 
mixture was then filtered through Celite. The filtrate was concentrated under 
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reduced pressure. Yields and ratio were determined by GC analysis of the crude 
reaction mixture. 
 
Reductive amination of 37a 
 
(5R*,8aR*)-5-hexyloctahydroindolizine (indolizidine 209D) (39a-cis). 
An analytical sample (5R*,8aR*)-5-hexyloctahydroindolizine38 was prepared 
following General Method. The crude residue was purified by flash column 
chromatography on silica gel (CH2Cl2/MeOH, 8:1) to give  known 39a-cis 
(indolizidine 209D)38 as only one isomer.  
 
Reductive amination of 39b 
 
An analytical sample 39b-cis and trans were prepared following General Method. 
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The crude residue was purified by flash column chromatography on silica gel 
(CH2Cl2/MeOH, 15:1) to give 39b-cis and 39b-trans. The stereochemistry of the 
39b-cis and 39b-trans were assigned by COSY, NOESY 2D experiments after ester 
group LiAlH4 reduction of 39b-cis and 39b-trans. 
 
(5R*,8aR*)-methyl 5-methyloctahydroindolizine-8a-carboxylate (39b-cis). 
1H NMR (CDCl3, 400 MHz) δ 1.08 (d, J = 6.44 Hz, 3H), 1.12–1.31 (m, 3H), 1.42–
1.48 (m, 1H), 1.60–1.83 (m, 4H), 1.96–2.06 (m, 1H), 2.19–2.25 (m, 1H), 2.96–3.10 
(m, 3H) 3.65 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 19.6, 20.7, 22.3, 31.7, 32.2, 
36.6, 46.1, 51.2, 51.3, 69.3 174.9; IR (CHCl3) umax 2969, 2858, 1735, 1366, 1216 
(cm-1); MS (FAB) m/z 198 ([M+1]+, 90), 154 (100), 136 (65), 107 (20); HRMS 
(FAB) calcd for C11H20NO2 198.1494 ([M+H]
+), found 198.1489. 
 
(5S*,8aR*)-methyl 5-methyloctahydroindolizine-8a-carboxylate (39b-trans). 
1H NMR (CDCl3, 400 MHz) δ 1.10 (d, J = 6.56 Hz, 3H), 1.21–1.38 (m, 1H), 1.48–
1.58 (m, 3H), 1.65–1.91 (m, 3H), 2.02–2.21 (m, 3H), 2.76–2.83 (m, 1H), 2.87 (dd, 
J = 7.72, 17.1 Hz, 1H), 3.18–3.25 (m, 1H), 3.73 (s, 3H); 13C NMR (CDCl3, 100 
MHz) δ 17.8, 19.9, 21.7, 27.8, 29.2, 36.8, 51.5, 51.8, 52.0, 66.7, 177.3; IR (CHCl3) 
umax 2924, 2853, 1680, 1396, 1259, 1022 (cm
-1); MS (FAB) m/z 198 ([M+1]+, 100), 










39b-cis S17  
To a solution of ester 39b-cis (70.0 mg, 0.354 mmol) in anhydrous THF (1 mL) at 
–78 °C was slowly added LiAlH4 (0.422 mL, 0.422 mmol, 1.0 M solution in THF). 
The reaction mixture was allowed to warm to rt for 1 h. H2O (80 mL), 10% aqueous 
NaOH solution (80 mL) and H2O (240 mL) were added to the mixture in that order. 
The resulting mixture was filtered through a glass funnel packed with Celite. The 
filtrate was concentrated under reduced pressure, and purified by flash column 
chromatography on silica gel (CH2Cl2/MeOH/28% aqueous NH3, 60:10:1) to give 
alcohol S17 (57.0 mg, 95%) as a colorless oil: 1H NMR (C6D6, 400 MHz) δ 0.81–
0.88 (m, 3H), 0.91 (d, J = 6.80 Hz, 3H), 1.04–1.16 (m, 2H), 1.19–1.36 (m, 3H), 
1.47–1.61 (m, 2H), 2.14 (ddd, J = 7.20, 10.6, 12.3 Hz, 1H), 2.58 (dd, J = 8.64, 16.8 
Hz, 1H) 2.64–2.75 (m, 2H), 3.19 (d, J = 10.0 Hz, 1H), 3.79 (d, J = 10.0 Hz, 1H); 
13C NMR (CDCl3, 75 MHz) δ 17.6, 18.4, 19.8, 25.1, 27.7, 32.1, 44.7, 52.1, 62.6, 
72.0; IR (CHCl3) umax 3354, 2926, 1633, 1464, 1299, 1140 (cm
-1); MS (FAB) m/z 
170 ([M+1]+, 100), 154 (20), 136 (15), 55 (60); HRMS (FAB) calcd for C10H20NO 




To a solution of ester 39b-trans (60.0 mg, 0.304 mmol) in anhydrous THF (1 mL) 
at –78 °C was slowly added LiAlH4 (0.364 mL, 0.364 mmol, 1.0 M solution in 
THF). The reaction mixture was allowed to warm to rt for 1 h. H2O (70 mL), 10% 
aqueous NaOH solution (70 mL) and H2O (210 mL) were added to the mixture in 
that order. The resulting mixture was filtered through a glass funnel packed with 
Celite. The filtrate was concentrated under reduced pressure, and purified by flash 
column chromatography on silica gel (CH2Cl2/MeOH/28% aqueous NH3, 60:10:1) 
to give alcohol S18 (48.0 mg, 93%) as a colorless oil: 1H NMR (C6D6, 400 MHz) δ 
1.16 (d, J = 6.10 Hz, 3H), 1.21–1.30 (m, 1H), 1.32–1.41 (m, 1H), 1.46–1.76 (m, 
8H), 1.96–2.03 (m, 1H), 2.32–2.39 (m, 1H), 2.74 (ddd, J = 5.30, 7.95, 11.8 Hz, 1H), 
3.04 (td, J = 6.90, 11.6 Hz, 1H), 3.34 (d, J = 10.1 Hz, 1H), 3.46 (d, J = 10.1 Hz, 
1H); 13C NMR (CDCl3, 75 MHz) δ 18.7, 21.9, 22.7, 29.6, 29.7, 31.5, 32.9, 51.1, 
52.9, 66.1; IR (CHCl3) umax 3394, 2929, 2869, 1646, 1460, 1145 (cm
-1); MS (FAB) 
m/z 170 ([M+1]+, 90), 154 (100), 136 (60), 107 (20); HRMS (FAB) calcd for 
C10H20NO 170.1545 ([M+H]




Reductive amination of 37c 
 
An analytical sample 39c-cis and trans were prepared following General Method. 
The crude residue was purified by flash column chromatography on silica gel 
(CH2Cl2/MeOH, 10:1) to give 39c-cis and 39c-trans. But 39c-cis and 39c-trans 
were obtained as a mixture of free base and salt form after a flash column 
chromatography on silica gel. Therefore, they were analyzed after transformation 
to hydrochloride salt form.  
The resultant product (10.0 mg, 24.0 mmol) was dissolved in MeOH (1 mL). To 
this solution was added 1.0 M aqueous HCl (50 mL), and then the solution was 
evaporated to dryness in vacuo to give the hydrochloride salt of 39c-cis and 39c-
trans as a light yellow gum. 
The stereochemistry of the 39b-cis and 39b-trans were assigned by comparing 





1H NMR (CDCl3, 400 MHz) δ 1.05 (s, 9H), 1.25–1.55 (m, 5H), 1.85–2.29 (m, 7H), 
2.31–2.45 (m, 1H), 3.13 (m, 1H), 3.34 (m, 1H), 3.50–3.69 (m, 1H), 4.09 (d, J = 
7.68 Hz, 1H), 4.35 (d, J = 7.32 Hz, 1H), 7.29–7.49 (m, 6H), 7.52–7.69 (m, 4H), 
11.8 (br s, 1H); 13C NMR (CDCl3, 75 MHz) δ 18.5, 18.6, 19.1, 19.3, 24.9, 25.6, 
26.8, 26.9 (3C), 35.2, 52.4, 63.9, 69.7, 127.8 (2C), 127.9 (2C), 130.0 (2C), 132.2, 
132.6, 135.5 (2C), 135.6 (2C); IR (CHCl3) umax 2930, 2857, 1737, 1428, 1364, 
1112 (cm-1); MS (FAB) m/z 408 ([M+1]+, 100), 138 (25), 136 (5); HRMS (FAB) 
calcd for C26H38NOSi 408.2723 ([M+H]




1H NMR (CDCl3, 400 MHz) δ 1.07 (s, 9H), 1.43–1.51 (m, 2H), 1.51 (d, J = 6.50 
Hz, 3H), 1.71–2.03 (m, 7H), 2.14–2.23 (m, 1H), 2.88–2.98 (m, 1H), 3.12–3.21 (m, 
1H), 3.71–3.81 (m, 1H), 3.97 (d, J = 10.7 Hz, 1H), 4.22 (d, J = 10.7 Hz, 1H), 7.34–
7.45 (m, 6H), 7.58–7.66 (m, 4H), 11.5 (br s, 1H); 13C NMR (CDCl3, 100 MHz) δ 
16.6, 17.8, 19.3, 19.5, 26.9, 27.4, 28.6, 29.6 (3C), 51.4, 56.4, 66.0, 72.2, 127.91 
(2C), 127.94 (2C), 130.0 (2C), 132.3, 132.6, 135.6 (2C), 135.7 (2C); IR (CHCl3) 
umax 2940, 2857, 1428, 1365, 1216, 1112 (cm
-1); MS (FAB) m/z 408 ([M+1]+, 100), 
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To a solution of 39c-cis (80.0 mg, 0.196 mmol) in THF (1 mL) was added TBAF 
(0.784 mL, 0.784 mmol, 1.0 M solution in THF). The solution was stirred for 2 h at 
rt, and then the reaction mixture was quenched with aqueous saturated NH4Cl and 
extracted with EtOAc twice. The combined organic layers were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (CH2Cl2/MeOH/28% aqueous NH3, 60:10:1) 








To a solution of 37c-trans (90.0 mg, 0.220 mmol) in THF (1 mL) was added 
TBAF (0.880 mL, 0.880 mmol, 1.0 M solution in THF). The solution was stirred 
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for 2 h at rt, and then the reaction mixture was quenched with aqueous saturated 
NH4Cl and extracted with EtOAc twice. The combined organic layers were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (CH2Cl2/MeOH/28% 
aqueous NH3, 60:10:1) to give identical product S18 (31.0 mg, 85%) as a colorless 
oil. 
Table S1. Model System Study for Reductive Amination. 
entry substrate reducing agent solvent T (°C) yield (%),
a 
cis:trans 
1b 37a NaCNBH3 MeOH –40 78%, 1:0 
2b 37a NaBH4 MeOH –40 85%, 1:0 
3b 37a Na(OAc)3BH MeOH –40 85%, 1:0 
4c 37a L-Selectride THF –78 80%, 1:0 
5d 37a Pd/C  MeOH rt 90%, 1:0 
6b 37b NaCNBH3 MeOH rt 83%, 5:1 
7b 37b NaCNBH3 MeOH 0 80%, 7.3:1 
8b 37b NaCNBH3 MeOH –40 92%, 24:1 
9b 37b NaCNBH3 THF –40 76%, 74:1 
10b 37b NaBH4 MeOH –40 80%, 9.5:1 
11b 37b Na(OAc)3BH MeOH –40 85%, 7:1 
12c 37b L-Selectride THF –78 75%, 1:11 
13d 37b Pd/C MeOH rt 73%, 1:12 
14c 37b LiEt3BH THF –78 95%, 1:2.3 
15b 37c NaCNBH3 MeOH –40 89%, 3:1 
16b 37c NaBH4 MeOH –40 91%, 5:1 
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17b 37c Na(OAc)3BH MeOH –40 89%, 2.4:1 
18c 37c L-Selectride THF –78 80%, 1:7 
19c 37c LiEt3BH THF –78 90%, 1:2 
20d 37c Pd/C MeOH rt 93%, 1:22 
aYields and ratio were determined by GC analysis. bGeneral Method A, cGeneral Method 
B, dGeneral Method C. 
 
IV-5. Total synthesis of (–)-Lepadiformine, (–)-Fasicularin 
 
(E)-methyl 6-oxododec-2-enoate (43). 
 
To a solution of alcohol S1939 (5.30 g, 23.4 mmol) in CH2Cl2 (80 mL) were added 
DMSO (20 mL) and Et3N (16.3 mL, 117 mmol) at 0 °C. The mixture was cooled to 
0 °C and charged with SO3·pyridine (13.0 g, 81.9 mmol). After 1 h, it was diluted 
with EtOAc, washed with water, dried over MgSO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash column chromatography 
on silica gel (hexane/EtOAc, 5:1) to give the ketone 43 (4.79 g, 90%) as a colorless 
liquid: 1H NMR (CDCl3, 400 MHz) d 0.56 (t, J = 7.04 Hz, 3H), 0.97 (br s, 6H), 
1.25 (q, J = 6.92 Hz, 2H), 2.13 (q, J = 7.56 Hz, 4H), 2.29 (t, J = 7.04 Hz, 2H), 3.37 
(s, 3H), 5.51 (d, J = 15.6 Hz, 1H), 6.61 (td, J = 6.72, 15.6 Hz, 1H); 13C NMR 
(CDCl3, 75 MHz) d 13.3, 21.8, 23.0, 25.3, 28.2, 30.9, 39.7, 42.0, 50.5, 120.8, 147.1, 
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165.8, 207.9; IR (CHCl3) umax 2953, 2930, 2857, 1722, 1272 (cm
-1); MS (FAB) m/z 
227 ([M+1]+, 93), 195 (100), 149 (38), 113 (57); HRMS (FAB) calcd for C13H23O3 
227.1647 ([M+H]+), found 227.1641. 
 
(E)-methyl 5-(2-hexyl-1,3-dioxolan-2-yl)pent-2-enoate (S20). 
 
A mixture of ketone 43 (4.00 g, 17.7 mmol), ethylene glycol (10 mL), and 
pyridinium p-toluenesulfonate (35.0 mg, 0.177 mmol) in dry benzene (50 mL) was 
heated to reflux under a Dean-Stark trap for 5 h. The reaction mixture was then 
allowed to cool to rt and the benzene was removed under reduced pressure. The 
residue was diluted with Et2O and washed with aqueous 5% Na2CO3 solution. The 
organic layer was dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (hexane/EtOAc, 
5:1) to give the S20 (4.10 g, 85%) as a colorless liquid: 1H NMR (CDCl3, 400 
MHz) d 0.84 (t, J = 7.00 Hz, 3H), 1.18–1.38 (m, 8H), 1.54 (dd, J = 6.48, 10.3 Hz, 
2H), 1.72 (dd, J = 5.48, 10.2 Hz, 2H), 2.23 (dd, J = 8.04, 16.4 Hz, 2H), 3.67 (s, 3H), 
3.85–3.93 (m, 4H), 5.78 (d, J = 15.6 Hz, 1H), 6.94 (td, J = 6.84, 15.6 Hz, 1H); 13C 
NMR (CDCl3, 100 MHz) d 14.0, 22.5, 23.7, 26.5, 29.4, 31.7, 35.1, 37.3, 51.3, 64.9 
(2C), 111.0, 120.6, 149.3, 167.0; IR (CHCl3) umax 2952, 1725, 1657, 1271 (cm
-1); 
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MS (FAB) m/z 271 ([M+1]+, 48), 195 (14), 185 (87), 113 (19); HRMS (FAB) calcd 
for C15H27O4 271.1909 ([M+H]




To a solution of methyl ester S20 (3.00 g, 11.1 mmol) in anhydrous THF (50 mL) 
was added dropwise DIBAL-H (27.7 mL, 27.7 mmol, 1.0 M solution in toluene) at 
–78 °C. After being stirred for 2 h at –78 °C, the reaction mixture was diluted with 
Et2O (50 mL), quenched with water (27 mL), and then stirred at rt for 1 h. This 
resulting mixture was filtered through a glass funnel packed with Celite. The 
filtrate was concentrated under reduced pressure. The resulting residue was purified 
by flash column chromatography on silica gel (hexane/EtOAc, 2:1) to give allylic 
alcohol 41 (2.48 g, 91%) as a colorless oil: 1H NMR (CDCl3, 400 MHz) d 0.78 (t, J 
= 7.40 Hz, 3H), 1.10–1.33 (m, 8H), 1.45–1.55 (m, 2H), 1.60 (t, J = 8.40, 2H), 2.01 
(td, J = 5.68, 10.1 Hz, 2H), 2.41 (br s, 1H), 3.83 (s, 4H), 3.95 (d, J = 4.88 Hz, 2H), 
5.50–5.63 (m, 2H); 13C NMR (CDCl3, 75 MHz) d 13.9, 22.4, 23.5, 26.3, 29.3, 31.6, 
36.2, 37.0, 63.2, 64.7 (2C), 111.3, 128.8, 132.2; IR (CHCl3) umax 3419, 2929, 2871, 
1670, 1455, 1088 (cm-1); MS (FAB) m/z 243 ([M+1]+, 15), 125 (25), 181 (7), 113 
(15); HRMS (FAB) calcd for C14H27O3 243.1960 ([M+H]
+), found 243.1953. 
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(2S,5S,E)-1-tert-butyl 2-(5-(2-hexyl-1,3-dioxolan-2-yl)pent-2-enyl) 5-
(benzyloxymethyl)pyrrolidine-1,2-dicarboxylate (42).  
 
To a solution of acid 8 (2.00 g, 5.96 mmol) and the allylic alcohol 41 (1.30 g, 5.36 
mmol) in CH2Cl2 (30 mL) were added DMAP (72.0 mg, 10 mol%) and EDCI (1.71 
g, 8.94 mmol) at 0 °C. The reaction mixture was stirred at rt for 2 h and then 
diluted with water. It was extracted with CH2Cl2 twice. The combined organic 
layers were washed with water, dried over MgSO4, filtered, and concentrated under 
reduced pressure. The resulting residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc, 10:1) to give the allylic ester 42 
(2.65 g, 88%) as a colorless oil: [a]24D –31.8 (c 1.00, CHCl3); 
1H NMR (CDCl3, 
400 MHz; two rotamers in a 3:2 ratio) d 0.85 (t, J = 6.41 Hz, 3H), 1.18–1.33 (m, 
8H), 1.37 (s, 5.4H), 1.39 (s, 3.6H), 1.56 (t, J = 8.75, 2H), 1.66 (t, J = 8.52, 2H), 
1.81–1.99 (m, 2H), 2.02–2.16 (m, 3H), 2.19–2.37 (m, 1H), 3.35 (dd, J = 7.52, 9.04 
Hz, 0.4H), 3.37–3.55 (m, 1.2H), 3.59 (dd, J = 3.16, 9.48 Hz, 0.4H), 3.90 (s, 4H), 
4.05 (dt, J = 3.16, 7.56 Hz, 0.4H), 4.15–4.25 (m, 1.2H), 4.29 (d, J = 8.88 Hz, 0.4H), 
4.43–4.61 (m, 4H), 5.48–5.59 (m, 1H), 5.70–5.82 (m, 1H), 7.27–7.37 (m, 5H); 13C 
NMR (CDCl3, 75 MHz; rotamer 1/rotamer 2) d 13.9, 22.4, 23.6, 26.4/26.1, 
27.6/27.8, 28.1/28.2 (3C), 28.8, 29.4, 31.6, 36.0/35.9, 37.2, 57.3/57.1, 59.9/59.6, 
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64.8 (2C), 65.4, 70.5/70.8, 73.0, 79.8/79.9, 111.1/111.2, 123.3/123.5, 127.2/127.3 
(2C), 128.1/128.2 (2C), 135.8, 136.4/136.2, 138.3/138.1, 153.6/154.0, 172.9/172.4; 
IR (CHCl3) umax 2932, 1746, 1701, 1388, 1169 (cm
-1); MS (FAB) m/z 560 ([M+1]+, 
7), 504 (10), 225 (100), 157 (65); HRMS (FAB) calcd for C32H50NO7 560.3587 
([M+H]+), found 560.3586. 
 
(2S,5S)-5-(benzyloxymethyl)-1-(tert-butoxycarbonyl)-2-((R)-5-(2-hexyl-1,3-
dioxolan-2-yl)pent-1-en-3-yl)pyrrolidine-2-carboxylic acid (40). 
 
To a solution of LiHMDS (12.4 mL, 12.4 mmol, 1.0 M solution in THF) in 
anhydrous THF (50 mL), at –78 °C under N2 atmosphere, was added dropwise a 
solution of 42 (2.00 g, 3.57 mmol) in anhydrous THF (10 mL). The reaction 
mixture was warmed to rt and stirred for 1 day. The reaction was quenched with 
aqueous saturated NH4Cl solution and extracted with EtOAc twice. The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure, to give the desired isomer 40 and its stereo isomer as a colorless 
oil (1.77 g, d.r. 10:1, crude 1H NMR spectrum), which was used in the next step 
without further purification.  
Compound 40: 1H NMR (CDCl3, 500 MHz) d 0.85 (t, J = 6.50, 3H), 1.19–1.34 (m, 
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10H), 1.40 (s, 9H), 1.48–1.57 (m, 3H), 1.61–1.69 (m, 1H), 1.81–1.99 (m, 3H), 
2.63–2.72 (m, 1H), 3.19 (t, J = 9.50 Hz, 1H), 3.31–3.43 (m, 2H), 3.81–3.92 (m, 
5H), 4.04–4.13 (m, 1H), 4.43 (d, J = 12.1 Hz, 1H), 4.45 (d, J = 12.1 Hz, 1H), 5.12–
5.21 (m, 2H), 5.43–5.53 (m, 1H), 7.26–7.35 (m, 5H); 13C NMR (CDCl3, 75 MHz) d 
14.0, 22.0, 22.5, 23.6, 26.3, 28.1 (3C), 28.3, 29.5, 31.7, 35.0, 36.9, 45.9, 60.0, 64.8, 
70.3, 73.2 (2C), 75.5, 76.5, 83.0, 111.4, 120.1, 127.7 (2C), 128.4 (2C), 135.6, 137.7, 
157.4, 172.6. 
Stereoisomer of 40: 1H NMR (CDCl3, 400 MHz) d 0.81–0.89 (m, 3H), 1.12–1.40 
(m, 12H), 1.44 (s, 9H), 1.47–1.55 (m, 2H), 1.56–1.68 (m, 2H), 1.83–1.94 (m, 3H), 
2.52–2.57 (m, 1H), 3.08 (t, J = 9.52 Hz, 1H), 3.26 (t, J = 8.84 Hz, 1H), 3.62 (dd, J 
= 3.15, 8.80 Hz, 1H), 3.75–3.80 (m, 2H), 3.82–3.89 (m, 1H), 3.91–3.99 (m, 1H), 
4.46 (d, J = 12.1 Hz, 1H), 4.53 (d, J = 12.0 Hz, 1H), 5.14–5.19 (m, 2H), 5.36–5.43 
(m, 1H), 7.26–7.37 (m, 5H); 13C NMR (CDCl3, 75 MHz) d 14.0, 21.9, 22.6, 23.7, 
25.5, 27.5, 28.2 (3C), 29.6, 31.8, 34.7, 37.2, 46.1, 59.7, 64.8, 69.4, 73.3 (2C), 75.7, 








dioxolan-2-yl)pent-1-en-3-yl)pyrrolidine-1,2-dicarboxylate (44).  
 
The crude product 40 obtained above (1.77 g) was dissolved in MeOH (15 mL), 
and TMS-diazomethane (3.00 mL, 2.0 M solution in hexane) was added dropwise, 
causing instantaneous bubbling, along with a change from colorless to yellow. 
After allowing the reaction to proceed for 10 min, the reaction was quenched with 
acetic acid (approximately 90 μL), at which time gas evolved and the reaction 
mixture became colorless. The solvent was removed under reduced pressure, and 
the residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 10:1) to give the desired isomer 44 (1.43 g, 79%) as a colorless oil, 
and its stereoisomer (170 mg, 9%) as a colorless oil. 
Compound 44: [a]24D –19.6 (c 1.00, CHCl3); 
1H NMR (CDCl3, 400 MHz; two 
rotamers in a 1:1 ratio) d 0.85 (t, J = 5.96, 3H), 1.15–1.33 (m, 10H), 1.40 (s, 9H), 
1.48–1.58 (m, 3H), 1.62–1.75 (m, 1H), 1.81–2.01 (m, 2H), 2.03–2.21 (m, 2H), 3.97 
(t, J = 9.80 Hz, 0.5H), 3.20 (t, J = 8.92 Hz, 0.5H), 3.41 (t, J = 9.48 Hz, 0.5H), 3.49 
(t, J = 8.64 Hz, 0.5H), 3.59 (s, 3H), 3.63–3.72 (m, 0.5H), 3.74–3.84 (m, 0.5H), 3.85 
(s, 4H), 4.03 (br s, 0.5H), 4.17 (br s, 0.5H), 4.42–4.62 (m, 2H), 5.03–5.20 (m, 2H), 
5.60–5.82 (m, 1H), 7.28–7.35 (m, 5H); 13C NMR (CDCl3, 75 MHz; rotamer 
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1/rotamer 2) d 14.0, 22.5, 23.1/23.3, 23.6, 26.3/26.9, 28.2 (3C), 29.5, 30.5, 31.7, 
35.2/35.8, 36.9/37.1, 46.8/48.0, 51.7, 59.1/59.2, 64.7, 69.5/70.4, 71.4/72.1, 73.0 
(2C), 79.7/80.3, 111.6, 117.5/117.6, 127.4 (3C), 128.3 (2C), 138.4 (2C), 
153.0/154.1, 174.1; IR (CHCl3) umax 2951, 2871, 1698, 1381 (cm
-1); MS (FAB) m/z 
574 ([M+1]+, 21), 518 (25), 352 (27), 248 (49); HRMS (FAB) calcd for C33H52NO7 
574.3744 ([M+H]+), found 573.3755. 
Stereoisomer of 44: [a]24D –10.1 (c 1.0, CHCl3); 
1H NMR (CDCl3, 400 MHz; two 
rotamers in a 3:2 ratio) d 0.82–0.91 (m, 3H), 1.11–1.38 (m, 10H), 1.40 (s, 9H), 
1.46–1.55 (m, 2H), 1.57–1.73 (m, 2H), 1.81–1.95 (m, 2H), 1.98–2.15 (m, 2H), 2.92 
(t, J = 8.88 Hz, 0.6H), 3.08 (t, J = 8.12 Hz, 0.4H), 3.23–3.33 (m, 0.4H), 3.37 (t, J = 
8.16 Hz, 0.6H), 3.64 (s, 3H), 3.68–3.74 (m, 1H), 3.75–3.89 (m, 4H), 4.17 (br s, 
0.4H), 4.31 (br s, 0.6H), 4.52 (br s, 2H), 5.04–5.14 (m, 2H), 5.60–5.75 (m, 1H), 
7.27–7.35 (m, 5H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) d 
14.06/14.02, 21.84, 22.5/22.9, 23.7, 24.8, 28.2 (3C), 29.5, 30.3, 31.8, 37.3/37.1, 
38.7, 47.6/46.8, 51.8, 59.3, 64.8, 68.1, 71.0/71.7, 73.0 (2C), 80.4, 111.7, 117.5, 
127.4 (3C), 128.3, 129.5 (2C), 130.8, 154.1/155.9, 174.3; IR (CHCl3) umax 2953, 
2867, 1697, 1335 (cm-1); MS (FAB) m/z 574 ([M+1]+, 50), 352 (35), 248 (73); 
HRMS (FAB) calcd for C33H52NO7 574.3744 ([M+H]




Reagent-controlled diastereoselective reductive amination. 
 
Method A (L-Selectride): To a solution of 44 (700 mg, 1.21 mmol) in dry CH2Cl2 
(5 mL) was added TFA (3 mL) at 0 °C. The reaction mixture was stirred for at rt for 
1 h, and the solvent and reagent were removed under reduced pressure. The 
resulting residue 45 was dissolved in anhydrous THF (6 mL). To this solution was 
added L-Selectiride (3.92 mL, 3.92 mmol, 1.0 M solution in THF) at –78 °C. The 
reaction mixture was stirred for 2 h at the same temperature and then quenched 
with aqueous saturated NH4Cl solution. It was poured into brine, and extracted 
with EtOAc twice. The combined organic layers were dried over Na2SO4 and 
concentrated. The resulting residue was filtered through a short pad of silica using 
EtOAc and the filtrate was concentrated under reduced pressure. 1H NMR analysis 
of the crude mixture verified the presence of major isomer 36b and minor isomer 
36a (36b/36a, 24:1). The residue was further purified by flash column 
chromatography on silica gel (hexane/EtOAc, 10:1) to give the major isomer 36b 
(438 mg, 87.5%) and a minor isomer 36a (18.0 mg, 3.6%). 
Method B (NaCNBH3): To a solution of 44 (500 mg, 0.870 mmol) in dry CH2Cl2 
(5 mL) was added TFA (3 mL) at 0 °C. The reaction mixture was stirred at rt for 1 
h, and the solvent and reagent were removed under reduced pressure. The resulting 
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residue 45 was dissolved in MeOH (5 mL). To this solution was added NaCNBH3 
(191 mg, 3.04 mmol) at –78 °C. The reaction mixture was stirred for 1 h at the 
same temperature and then warmed to rt. The reaction mixture was quenched with 
aqueous saturated NH4Cl solution. It was poured into brine, and extracted with 
EtOAc twice. The combined organic layers were dried over Na2SO4 and 
concentrated. The resulting residue was filtered through a short pad of silica using 
EtOAc and the filtrate was evaporated to dryness in vacuo. 1H NMR analysis of the 
crude mixture verified the presence of major isomer 36a and minor isomer 36b 
(36a/36b, 12:1). The residue was further purified by flash column chromatography 
on silica gel (hexane/EtOAc, 7:1) to give the major isomer 36a (383 mg, 80.3%) 




As a colorless oil: [a]24D –14.3 (c 0.82, CHCl3); 
1H NMR (CDCl3, 400 MHz) d 
0.86 (t, J = 6.48, 3H), 1.14–1.41 (m, 11H), 1.52–1.74 (m, 4H), 1.83–1.94 (m, 1H), 
1.97–2.13 (m, 2H), 2.35–2.45 (m, 1H), 2.81 (dt, J = 4.0, 9.8 Hz, 1H), 3.06 (t, J = 
8.76 Hz, 1H), 3.24 (q, J = 7.04 Hz, 1H), 3.39 (dd, J = 4.08, 9.00 Hz, 1H), 3.56 (s, 
3H), 4.43 (d, J = 12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 1H), 4.87–5.00 (m, 2H), 5.63–
5.75 (m, 1H), 7.27–7.35 (m, 5H); 13C NMR (CDCl3, 125 MHz; rotamer 1/rotamer 
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2) d 14.1, 22.7, 23.9, 26.3, 26.9, 27.2, 29.2, 29.5, 31.9, 36.7, 44.1, 51.7, 58.1, 64.6, 
72.3, 73.2, 75.2, 115.4, 127.4, 127.5 (2C), 128.2 (2C), 138.6, 139.1, 177.0; IR 
(CHCl3) umax 2927, 2855, 1728, 1455, 1100 (cm
-1); MS (FAB) m/z 414 ([M+1]+, 






As a colorless oil: [a]24D –15.6 (c 0.67, CHCl3); 
1H NMR (CDCl3, 400 MHz) d 
0.87 (t, J = 6.48, 3H), 1.11–1.34 (m, 10H), 1.40–1.51 (m, 2H), 1.52–1.65 (m, 2H), 
1.66–1.84 (m, 2H), 1.85–1.95 (m, 2H), 2.70 (td, J = 4.48, 8.92 Hz, 1H), 3.11 (t, J = 
9.16 Hz, 1H), 3.27–3.36 (m, 1H), 3.55–3.60 (m, 1H), 3.61 (s, 3H), 3.65 (dd, J = 
2.81, 9.28 Hz, 1H), 4.47 (s, 2H), 5.03–5.11 (m, 2H), 6.04 (ddd, J = 9.06, 10.4, 16.8 
Hz, 1H), 7.21–7.34 (m, 5H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) d 
14.1, 22.6, 25.58, 25.59, 27.3, 28.1, 29.7, 31.9, 32.7, 34.8, 43.8, 51.3, 51.6, 57.7, 
70.4, 72.0, 73.1, 116.2, 127.3, 127.5 (2C), 128.2 (2C), 138.5, 138.7, 178.0; IR 
(CHCl3) umax 2927, 2857, 1733, 1454 (cm
-1); MS (FAB) m/z 414 ([M+1]+, 100), 
393 (20), 292 (28), 154 (76); HRMS (FAB) calcd for C26H40NO3 414.3008 






To a solution of ester 36b (400 mg, 0.953 mmol) in anhydrous THF (6 mL) at –
78 °C was slowly added LiAlH4 (2.88 mL, 2.88 mmol, 1.0 M solution in THF). 
The reaction mixture was allowed to warm to rt for 1 h. H2O (0.7 mL), 10% 
aqueous NaOH solution (0.7 mL) and H2O (2.1 mL) were added to the mixture in 
that order. The resulting mixture was filtered through a glass funnel packed with 
Celite. The filtrate was concentrated under reduced pressure, and purified by flash 
column chromatography on silica gel (hexane/EtOAc, 2:1) to give alcohol 46b 
(355 mg, 96%) as a colorless oil: [a]24D –15.8 (c 0.60, CHCl3); 
1H NMR (CDCl3, 
400 MHz) d 0.81–0.93 (m, 3H), 1.08–1.38 (m, 11H), 1.39–1.49 (m, 2H), 1.54–1.69 
(m, 3H), 1.70–1.82 (m, 2H), 1.96–2.07 (m, 1H), 2.33 (dt, J = 5.43, 11.4 Hz, 1H), 
2.43–2.52 (m, 1H), 2.94 (d, J = 10.0 Hz, 1H), 3.15–3.23 (m, 1H), 3.27 (t, J = 8.64 
Hz, 1H), 3.29 (d, J = 10.0 Hz, 1H), 3.48 (dd, J = 4.92, 8.76 Hz, 1H), 4.49 (s, 2H), 
4.97 (dd, J = 1.84, 10.2 Hz, 1H), 5.03 (d, J = 17.4 Hz, 1H), 5.71 (ddd, J = 9.04, 
10.0, 17.0 Hz, 1H), 7.28–7.45 (m, 5H); 13C NMR (CDCl3, 100 MHz) d 14.0, 22.6, 
24.5, 25.8, 27.0, 29.5, 29.6, 29.8, 31.9, 36.9, 44.1, 59.8, 63.9, 65.7, 67.9, 73.2, 75.6, 
115.8, 127.4 (3C), 128.2 (2C), 138.3, 140.0; IR (CHCl3) umax 3402, 2928, 2856, 
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1454 (cm-1); MS (FAB) m/z 386 ([M+1]+, 100), 354 (76), 264 (35); HRMS (FAB) 
calcd for C25H40NO2 386.3059 ([M+H]





To a solution of alcohol 46b (300 mg, 0.778 mmol) in anhydrous Et2O (5 mL) 
were added Et3N (0.870 mL, 6.24 mmol), MsCl (0.240 mL, 3.12 mmol) at 0 °C. 
The reaction mixture was stirred for 1.5 h at 0 °C. The solution was quenched with 
28% aqueous NH3 solution and extracted with CH2Cl2 twice. The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated. The 
resulting mixture was filtered through a short pad of silica using CH2Cl2/MeOH 
(10:1). The filtrate was evaporated to dryness in vacuo to give aziridinium 48b as a 
light yellow oil. 
To a slurry of copper iodide (445 mg, 2.34 mmol) in anhydrous THF (4 mL) was 
added a solution of allylmagnesium bromide (4.68 mL, 4.68 mmol, 1.0 M solution 
in Et2O) at –78 °C under N2 atmosphere. The resulting mixture was stirred for 1 h 
at 0 °C. It was cooled again to –78 °C, and a solution of aziridinium 48b in 
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anhydrous THF (3 mL) was then added. After 2 h, the reaction mixture was 
allowed to slowly warm to rt. The dark blue result was poured into a solution of 
aqueous saturated NH4Cl solution, the aqueous phase was extracted with CH2Cl2, 
and the combined organic layers were then dried over Na2SO4. The solvent was 
evaporated and the residue was purified by flash column chromatography on silica 
gel (CH2Cl2/MeOH, 15:1) to give 47b (190 mg, 60% from 46b) as a light yellow 
oil: [a]24D –22.7 (c 0.70, CHCl3); 
1H NMR (CDCl3, 400 MHz) d 0.86 (t, J = 6.60 
Hz, 3H), 1.04–1.17 (m, 1H), 1.17–1.33 (m, 10H), 1.32–1.44 (m, 3H), 1.45–1.61 (m, 
3H), 1.72 (td, J = 9.32, 11.8 Hz, 1H), 1.76–1.85 (m, 1H), 1.94–2.04 (m, 1H), 2.09 
(dd, J = 7.64, 15.3 Hz, 2H), 2.25 (dt, J = 3.40, 10.2 Hz, 1H), 2.44–2.53 (m, 1H), 
3.10–3.18 (m, 1H), 3.21 (d, J = 8.68 Hz, 1H), 3.49 (dd, J = 4.52, 8.60 Hz, 1H), 
4.47 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.0 Hz, 1H), 4.83–5.02 (m, 4H), 5.70–5.83 
(m, 2H), 7.25–7.37 (m, 5H); 13C NMR (CDCl3, 75 MHz) d 14.1, 22.6, 24.4, 25.9, 
26.8, 27.6, 28.2, 29.6, 32.0, 32.2, 37.8, 45.9, 58.8, 65.6, 65.9, 67.9, 73.1, 76.6, 
113.4, 114. 6, 127.4, 127.5 (2C), 128.2 (2C), 138.6, 140.0, 141.3; IR (CHCl3) umax 
2927, 2856, 1738, 1111 (cm-1); MS (FAB) m/z 410 ([M+1]+, 100), 307 (20), 154 
(50); HRMS (FAB) calcd for C28H44NO 410.3423 ([M+H]











47b 49b  
To a solution of 47b (100 mg, 0.240 mmol) in CH2Cl2 (8 mL) was added second-
generation Grubbs’ catalyst (10.0 mg, 5 mol %). The reaction mixture was heated 
to 40 °C for 1 h and then cooled to rt. The mixture was concentrated, the residue 
was purified by flash column chromatography on silica gel (CHCl3/MeOH/28% 
aqueous NH3, 150:9:1) to give 49b (82.0 mg, 90%) as a colorless oil: [a]
24
D –10.7 
(c 0.50, CHCl3); 
1H NMR (CD3OD, 400 MHz) d 0.86 (t, J = 6.44 Hz, 3H), 1.11–
1.38 (m, 10H), 1.39–1.48 (m, 1H), 1.49–1.61 (m, 2H), 1.62–1.95 (m, 4H), 1.96–
2.06 (m, 2H), 2.07–2.24 (m, 3H), 2.40–2.58 (m, 2H), 3.40 (br s, 1H) 3.50 (dd, J = 
6.36, 9.32 Hz, 1H), 3.68 (dd, J = 7.84, 9.52 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 
4.57 (d, J = 11.9 Hz, 1H), 5.40 (dd, J = 1.61, 9.68 Hz, 1H), 5.46–5.54 (m, 1H), 
7.23–7.37 (m, 5H); 13C NMR (CD3OD, 75 MHz) d 14.4, 23.7, 24.4, 25.3, 25.7, 
27.1, 27.7, 30.6, 32.7, 32.9, 33.8, 36.1, 42.7, 65.2, 68.0, 74.0, 76.6, 126.9, 128.6 
(2C), 129.3 (3C), 131.8, 139.6; IR (CHCl3) umax 2925, 2855, 1736, 1244 (cm
-1); 
MS (FAB) m/z 382 ([M+1]+, 100), 322 (24), 154 (45); HRMS (FAB) calcd for 
C26H40NO 382.3110 ([M+H]










To a solution of 49b (70.0 mg, 0.175 mmol) in MeOH (4 mL) was added 10% 
Pd/C (140 mg, 200% wt. of 49b). The flask was evacuated, filled with H2, and 
stirred at rt for 12 h. The mixture was then filtered through Celite. The filtrate was 
concentrated and the residue was purified by flash column chromatography on 
silica gel (CHCl3/MeOH/28% aqueous NH3, 150:10:1) to give 34 (46.0 mg, 92%) 
as a colorless oil: [a]24D +10.3 (c 0.45, MeOH); 
1H NMR (CDCl3, 400 MHz) d 0.86 
(t, J = 6.40 Hz, 3H), 1.02–1.15 (m, 2H), 1.17–1.31 (m, 12H), 1.32–1.39 (m, 2H), 
1.40–1.47 (m, 1H), 1.47–1.79 (m, 9H), 1.84–1.93 (m, 2H), 2.16–2.25 (m, 1H), 
3.04–3.14 (m, 1H), 3.28 (dd, J = 6.24, 9.96 Hz, 1H), 3.50 (dd, J = 5.84, 10.2 Hz, 
1H); 13C NMR (CDCl3, 100 MHz) d 14.0, 22.6, 23.8, 24.4, 25.8, 25.9, 26.3, 26.9, 
27.6, 29.5, 31.2, 31.9, 38.0, 39.4, 41.7, 60.2, 64.8, 66.2, 66.6; IR (CHCl3) umax 
3407, 2926, 2857, 1462 (cm-1); MS (FAB) m/z 294 ([M+1]+, 100), 262 (17), 154 
(22); HRMS (FAB) calcd for C19H36NO 294.2797 ([M+H]







Conversion of 34 (20.0 mg, 68.0 μmol) into 4 (20.0 mg, 88%) was effected 
following the same procedure described by Kibayashi et al.: [a]24D –6.97 (c 0.47, 
MeOH); 1H NMR (pyridine-d5, 400 MHz) d 0.84 (t, J = 6.44 Hz, 3H), 0.95–1.10 
(m, 2H), 1.11–1.32 (m, 14H), 1.33–1.58 (m, 7H), 1.78 (td, J = 4.6, 12.9 Hz, 1H), 
1.87 (qd, J = 3.92, 12.4 Hz, 1H), 1.92–1.99 (m, 1H), 2.54 (d, J = 12.2 Hz, 1H), 
2.92 (ddt, J = 2.68, 5.56, 11.2 Hz, 1H), 3.28 (ddd, J = 1.80, 4.38, 14.5 Hz, 1H), 
3.38 (dd, J = 12.0, 14.5 Hz, 1H), 3.52–3.62 (m, 1H); 13C NMR (pyridine-d5, 100 
MHz) d 14.2, 19.3, 22.7, 22.9, 24.0, 26.3, 27.2, 27.7, 29.5, 30.2, 32.1, 32.4, 34.1, 
34.3, 40.2, 46.1, 46.5, 52.3, 56.3, 111.5; IR (CHCl3) umax 3388, 2927, 2858, 2050, 
1463 (cm-1); MS (CI) m/z 335 ([M+1]+, 18), 308 (15), 277 (21), 276 (100); HRMS 
(CI) calcd for C20H35N2S 335.2521 ([M+H]






To a solution of ester 36a (300 mg, 0.725 mmol) in anhydrous THF (5 mL) at –
78 °C was slowly added LiAlH4 (2.16 mL, 2.16 mmol, 1.0 M solution in THF). 
The reaction mixture was allowed to warm to rt for 1 h. H2O (0.54 mL), 10% 
aqueous NaOH solution (0.54 mL) and H2O (1.62 mL) were added in to the 
mixture in that order. This resulting mixture was filtered through a glass funnel 
packed with Celite. The filtrate was concentrated under reduced pressure, and 
purified by flash column chromatography on silica gel (hexane/EtOAc, 2:1) to give 
alcohol 46a (272 mg, 97%) as a colorless oil: [a]24D –50.2 (c 1.00, CHCl3); 
1H 
NMR (CDCl3, 400 MHz) d 0.86 (t, J = 6.84 Hz, 3H), 1.14–1.33 (m, 10H), 1.36–
1.65 (m, 5H), 1.66–1.87 (m, 3H), 1.89–2.02 (m, 2H), 2.64–2.74 (m, 1H), 3.16 (t, J 
= 7.56 Hz, 1H), 3.22 (d, J = 10.1 Hz, 1H), 3.32 (d, J = 10.1 Hz, 1H), 3.32–3.41 (m, 
2H), 4.45 (d, J = 12.1 Hz, 1H), 4.50 (d, J = 12.1 Hz, 1H), 4.90–5.00 (m, 2H), 5.71 
(ddd, J = 7.92, 10.3, 17.1 Hz, 1H), 7.28–7.36 (m, 5H); 13C NMR (CDCl3, 75 MHz) 
d 14.0, 22.6, 23.3, 24.1, 27.0, 28.34, 28.39, 29.3, 31.7, 35.5, 42.7, 51.3, 56.9, 64.2, 
69.6, 73.2, 75.3, 114.7, 127.5, 127.6 (2C), 128.3 (2C), 138.2, 139.9; IR (CHCl3) 
umax 3398, 2927, 2856, 1455 (cm
-1); MS (FAB) m/z 386 ([M+1]+, 100), 307 (17), 









To a solution of alcohol 46a (200 mg, 0.518 mmol) in anhydrous Et2O (5 mL) was 
added Et3N (0.570 mL, 4.08 mmol), MsCl (0.150 mL, 2.04 mmol) at 0 °C. The 
reaction mixture was stirred for 1.5 h at 0 °C. The solution was quenched with 28% 
aqueous NH3 solution and extracted with CH2Cl2 twice. The combined organic 
layers were washed with brine, dried over Na2SO4, and concentrated. The resulting 
mixture was filtered through a short pad of silica using CH2Cl2/MeOH (10:1). The 
filtrate was evaporated to dryness in vacuo, to give aziridinium 48a as a light 
yellow oil: 1H NMR (CDCl3, 500 MHz) d 0.86 (t, J = 6.80 Hz, 3H), 1.13–1.32 (m, 
7H), 1.41–1.52 (m, 3H), 1.60–1.72 (m, 3H), 1.78–1.85 (m, 1H), 1.81–1.86 (m, 1H), 
1.92–2.05 (m, 2H), 2.43–2.49 (m, 1H), 2.85–2.93 (m, 1H), 3.31 (t, J = 8.85 Hz, 
1H), 3.37–3.47 (m, 1H), 3.41 (d, J = 10.7 Hz, 1H), 3.46 (dd, J = 3.6, 8.90 Hz, 1H), 
3.51 (d, J = 10.7 Hz, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 
4.97–5.06 (m, 2H), 5.80 (ddd, J = 8.35, 10.2, 18.5 Hz, 1H), 7.28–7.35 (m, 5H); MS 
(FAB) m/z 368 ([M+1]+, 100), 386 (20), 102 (19); HRMS (FAB) calcd for 
C25H38NO 368.2953 ([M+H]
+), found 368.2940.  
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To a slurry of copper iodide (290 mg, 1.53 mmol) in anhydrous THF (3 mL) was 
added a solution of allylmagnesium bromide (3.06 mL, 3.06 mmol, 1.0 M solution 
in Et2O) dropwise at –78 °C under N2 atmosphere. The resulting mixture was 
stirred for 1 h at 0 °C. It was cooled again to –78 °C, and a solution of aziridinium 
48a in anhydrous THF (2 mL) was then added. After 2 h, the reaction mixture was 
allowed to slowly warm to rt. The dark blue result was poured into a solution of 
aqueous saturated NH4Cl solution, the aqueous phase was extracted with CH2Cl2, 
and the combined organic layers were then dried over Na2SO4. The solvent was 
evaporated and the residue was purified by flash column chromatography on silica 
gel (CH2Cl2/MeOH, 15:1) to give 47a (139 mg, 65% from 59a) as a light yellow 
oil: [a]24D –58.0 (c 0.60, CHCl3); 
1H NMR (CDCl3, 400 MHz) d 0.86 (t, J = 6.68 
Hz, 3H), 1.10–1.31 (m, 10H), 1.32–1.73 (m, 10H), 1.89–2.04 (m, 2H), 2.07–2.21 
(m, 1H), 2.68–2.77 (m, 1H), 3.03 (t, J = 9.08 Hz, 1H), 3.31 (tt, J = 3.64, 12.6 Hz, 
1H), 3.44 (dd, J = 3.48, 8.72 Hz, 1H), 4.45 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 12.0 
Hz, 1H), 4.83–5.00 (m, 4H), 5.75–5.88 (m, 2H), 7.25–7.37 (m, 5H); 13C NMR 
(CDCl3, 100 MHz) d 14.1, 22.6, 23.9, 24.7, 26.8, 28.43, 28.49, 29.4, 30.3, 31.9, 
35.7, 37.9, 45.7, 51.0, 57.1, 67.4, 73.1, 76.0, 113.5, 113.9, 127.4, 127.5 (2C), 128.3 
(2C), 138.7, 140.2, 141.1; IR (CHCl3) umax 2927, 2856, 1738, 1098 (cm
-1); MS 
(FAB) m/z 410 ([M+1]+, 100), 322 (22), 307 (13), 154 (45); HRMS (FAB) calcd for 
C28H44NO 410.3423 ([M+H]





To a solution of 47a (70.0 mg, 0.170 mmol) in CH2Cl2 (7 mL) was added second-
generation Grubbs’ catalyst (7.20 mg, 5 mol%). The reaction mixture was heated to 
40 °C for 1 h and then cooled to rt. The mixture was concentrated, the residue was 
purified by flash column chromatography on silica gel (CHCl3/MeOH/28% 
aqueous NH3, 150:9:1) to give 49a (58.0 mg, 90%) as a colorless oil: [a]
24
D –47.4 
(c 0.50, CHCl3); 
1H NMR (CD3OD, 400 MHz) d 0.90 (t, J = 6.64 Hz, 3H), 1.22–
1.41 (m, 10H), 1.43–1.58 (m, 2H), 1.67–1.84 (m, 2H), 1.85–2.07 (m, 4H), 2.08–
2.35 (m, 4H), 2.87–2.98 (m, 1H), 3.61–3.76 (m, 3H), 4.06–4.19 (m, 1H), 4.57 (d, J 
= 11.8 Hz, 1H), 4.71 (d, J = 11.8 Hz, 1H), 5.40 (dd, J = 1.64, 9.80 Hz, 1H), 5.60 
(dd, J = 2.84, 9.52 Hz, 1H), 7.27–7.45 (m, 5H); 13C NMR (CD3OD, 100 MHz) d 
15.1, 20.7, 22.8, 24.3, 26.4, 27.5, 27.8, 28.2, 31.1, 32.2, 32.6, 33.5, 36.5, 61.4, 63.9, 
70.3, 75.4, 77.7, 128.0, 128.7, 129.9 (2C), 130.1, 130.3 (2C), 139.4; IR (CHCl3) 
umax 2926, 2581, 1467, 1113 (cm
-1); MS (FAB) m/z 382 ([M+1]+, 100), 260 (12), 
136 (35); HRMS (FAB) calcd for C26H40NO 382.3110 ([M+H]
+), found 382.3105. 
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(–)-lepadiformin A (3a)  
To a solution of 49a (40.0 mg, 0.100 mmol) in MeOH (3 mL) was added 10% 
Pd/C (80.0 mg, 200% wt. of 49a). The flask was evacuated, filled with H2, and 
stirred at rt for 12 h. The mixture was then filtered through Celite. The filtrate was 
concentrated and the residue was purified by flash column chromatography on 
silica gel (CHCl3/MeOH/28% aqueous NH3, 150:10:1) to give 3a (26.0 mg, 89%) 
as a colorless oil: [a]24D –14.1 (c 0.37, MeOH); 
1H NMR (CDCl3, 400 MHz) d 0.85 
(t, J = 6.52 Hz, 3H), 1.00 (qd, J = 3.28, 12.4 Hz, 1H), 1.11–1.37 (m, 12H), 1.38–
1.82 (m, 15H), 3.06–3.16 (m, 1H), 3.20 (d, J = 8.59 Hz, 1H), 3.28–3.38 (m, 2H); 
13C NMR (CDCl3, 75 MHz) d 14.0, 22.6 (2C), 23.2, 24.2, 26.3, 27.5 (2C), 28.2, 
29.6, 30.5, 31.8, 34.1, 38.2, 40.0, 53.2, 58.3, 62.2, 67.1; IR (CHCl3) umax 3289, 
2929, 2857, 1466 (cm-1); MS (FAB) m/z 294 ([M+1]+, 50), 176 (22), 136 (65); 
HRMS (FAB) calcd for C19H36NO 294.2797 ([M+H]
+), found 294.2800. 
 
(-)-Lepadiformine A Hydrochloride. 
The free base 3a (10.0 mg, 34.0 μmol) was dissolved in MeOH (1 mL). To this 
solution was added 1.0 M aqueous HCl (50 mL), and then the solution was 
evaporated to dryness in vacuo to give the hydrochloride salt of 3a as a white gum: 
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[a]24D +2.42 (c 0.54, CHCl3); 
1H NMR (CDCl3, 500 MHz) d 0.84 (t, J = 6.75 Hz, 
3H), 0.96–1.06 (m, 1H), 1.14–1.40 (m, 12H), 1.42–1.51 (m, 1H), 1.62–1.83 (m, 
5H), 1.88–1.97 (m, 2H), 1.99–2.06 (m, 2H), 2.11–2.16 (m, 2H), 2.30–2.50 (m, 2H), 
3.57 (d, J = 13.1 Hz, 2H), 3.64 (t, J = 11.5 Hz, 1H) 4.15 (d, J = 12.6 Hz, 1H), 5.20 
(br s, 1H) 10.2 (br s, 1H); 13C NMR (CDCl3, 75 MHz) d 14.0, 19.1, 22.4, 22.5, 23.2, 
24.2, 24.8, 26.3, 26.4, 29.0, 29.8, 30.7, 31.6, 33.7, 36.1, 58.7, 59.8, 63.4, 77.2; IR 
(CHCl3) umax 3409, 2832, 1461 (cm
-1); MS (FAB) m/z 294 ([M–35]+, 55), 276 (22), 










To a solution of 6a (3.20 g, 4.76 mmol) in acetone (30 mL) was added K2CO3 
(720 mg, 5.24 mmol) at rt. After stirring the mixture for 1 h, methyl iodide (0.320 
mL, 5.24 mmol) was added dropwise. The resulting mixture was heated under 
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reflux for 12 h and then cooled to rt. After the white residue had been filtered off, 
the filtrate was concentrated under reduced pressure. The resulting residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc, 4:1) to give 
the known ester 182 (2.97 g, 91%) as a colorless oil. 
 
(2S,5S)-1-tert-butyl 2-methyl 5-(benzyloxymethyl)-2-((S)-5-(tert-
butyldiphenylsilyloxy) -1-oxopentan-2-yl)pyrrolidine-1,2-dicarboxylate (51). 
 
A solution of 18 (2.80 g, 4.16 mmol) in a mixture CH2Cl2 (10 ml) and MeOH (2.5 
ml) was cooled to –78 °C. Ozone was bubbled through the solution until a blue 
color persisted. After TLC indicated the absence of starting material, the ozone 
inlet tube was replaced with nitrogen and nitrogen was bubbled through the 
solution for 20 min to remove any excess ozone. Triphenylphosphine (1.63 g, 6.24 
mmol) was added in one portion, the cooling bath was removed and the mixture 
was stirred for 3 h at rt. The solution was concentrated and the residue was purified 
by flash column chromatography on silica gel (hexane/EtOAc, 4:1) to afford the 
aldehyde 51 (2.54 g, 89%) as a colorless oil: [a]24D –19.8 (c 1.0, CHCl3); 
1H NMR 
(CDCl3, 400 MHz; two rotamers in a 1:1 ratio) δ 0.95–1.06 (m, 9H), 1.33 (s, 4.5H), 
1.37 (s, 4.5H), 1.41–1.73 (m, 3H), 1.90–2.18 (m, 3H), 2.41–2.55 (m, 1H), 3.33–
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3.51 (m, 2H), 3.52–3.73 (m, 6.5H), 3.88 (dd, J = 3.28, 9.24 Hz, 0.5H), 4.01–4.08 
(m, 0.5H), 4.17–4.24 (m, 0.5H), 4.45–4.6 (m, 2H), 7.25–7.42 (m, 11H), 7.56–7.65 
(m, 4H), 9.91–10.1 (m, 1H); 13C NMR (CDCl3, 100 MHz; rotamer 1/rotamer 2) δ 
18.9/19.0, 22.7/23.2, 26.6/26.7 (3C), 27.3, 27.9/28.0 (3C), 30.1/30.3, 31.1/31.6, 
52.3/52,4, 54.0/54.1, 58.1/58.5, 63.1/63.4, 68.9/69.5, 70.3/71.1, 72.80/72.82, 
80.3/80.7, 95.8, 127.24/127.28 (2C), 127.4/127.4 (4C), 128.1/128.2 (2C), 129.4 
(2C), 133.4/133.5, 135.26/135.28 (4C), 138.0/138.2, 151.9/152.8, 174.2/174.7, 
202.2/202.8; IR (CHCl3) umax 2931, 2857, 1737, 1697, 1455, 1380, 1109 (cm
-1); 
MS (FAB) m/z 688 ([M+1]+, 7), 588 (15), 248 (40), 91 (100); HRMS (FAB) calcd 
for C40H54NO7Si 699.3670 ([M+H]
+), found 688.3673. 
 
Dimethyl 2-oxohexylphosphonate (54). 
 
To a suspension of sodium hydride (440 mg, 11.0 mmol, 60% mineral oil) in dried 
THF (20 mL) was added the dimethyl (2-oxopropyl)phosphonate (1.65 g, 10.0 
mmol) at 0 °C. The resulting mixture was stirred for 1 h at same temperature. Then, 
a solution of n-butyllithium (6.56 mL, 10.5 mmol, 1.6 M solution in hexane) was 
added dropwise to the mixture at 0 °C and stirred for 1 h at same temperature. The 
1-bromopropane (0.820 mL, 9.00 mmol) was added, the resulting mixture was 
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allowed to reach rt and stirred during 3 h. The reaction was quenched with 2.0 M 
aqueous HCl solution, and the mixture was extracted with chloroform twice. The 
combined organic layer were dried over MgSO4, filtered, and concentrated under 
reduced pressure. The resulting residue was purified by flash column 
chromatography on silica gel to give 54 (1.67 g, 80%) as a colorless liquid: 1H 
NMR (CDCl3, 300 MHz) d 0.78 (t, J = 7.20 Hz, 3H), 1.18 (qd, J = 7.50, 14.7 Hz, 
2H), 1.44 (pentet, J = 7.20 Hz, 2H), 2.49 (t, J = 6.90 Hz, 2H), 2.93 (s, 1H), 3.01 (s, 
1H), 3.64 (s, 3H), 3.68 (s, 3H); 13C NMR (CDCl3, 75 MHz) d 13.0, 21.2, 24.6, 39.4, 
41.1, 42.9, 52.1, 201.0; IR (CHCl3) umax 3448, 2960, 2874, 1715, 1249 (cm
-1); MS 
(FAB) m/z 209 ([M+1]+, 100), 137 (10), 125 (5); HRMS (FAB) calcd for C8H18O4P 






To a stirred suspension of NaH (182 mg, 4.47 mmol, 60% dispersion in mineral 
oil) in THF (10 mL) was added 51 (1.16 g, 5.58 mmol) at 0 °C, and the resulting 
solution was stirred at 0 °C for 15min. To the reaction mixture was added a 
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solution of 54 (2.50 g, 3.72 mmol) in THF (5 mL) at 0 °C, and the resulting 
mixture was stirred at rt for 10min. After it was refluxed for 3 h, the mixture was 
cooled to rt and poured into water and extracted with CH2Cl2 twice. The combined 
organic layers were washed with saturated NH4Cl and brine, dried over MgSO4, 
and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 3:1) to give 52 (2.01 g, 70%) as a 
colorless oil: [a]24D –16.7 (c 1.0, CHCl3); 
1H NMR (CDCl3, 400 MHz; two 
rotamers in a 1:1 ratio) δ 0.89 (t, J = 7.24 Hz, 3H), 1.02 (s, 9H), 1.30 (s, 9H), 1.35 
(s, 4H), 1.51–1.63 (m, 6H), 1.82–1.97 (m, 1H), 1.98–2.19 (m, 3H), 2.52 (t, J = 7.44 
Hz, 2H), 3.10–3.23 (m, 1H), 3.39–3.46 (m, 0.5H), 3.50 (t, J = 9.08 Hz, 0.5H), 3.60 
(s, 3H), 3.65–3.73 (m, 0.5H), 3.89 (br d, J = 7.08 Hz, 0.5H), 3.99–4.07 (m, 0.5H), 
4.14–4.23 (m, 0.5H), 4.44–4.62 (m, 2H), 6.02–6.18 (m, 1H), 6.78–6.89 (m, 1H), 
7.26–7.42 (m, 11H), 7.56–7.65 (m, 4H); 13C NMR (CDCl3, 100 MHz; rotamer 
1/rotamer 2) δ 13.7, 18.9, 22.1, 25.1/25.7, 26.0/26.2, 26.6 (3C), 26.8, 27.9/28.0 
(3C), 30.8/31.1, 31.8, 39.5/40.0, 46.4/46.6, 51.8, 58.5/58.9, 63.5, 68.6/69.0, 
70.9/71.4, 72.7, 79.9/80.4, 95.8, 127.24/127.28 (2C), 127.4 (4C), 128.0/128.1 (2C), 
129.3 (2C), 131.5/131.7, 133.5/133.6 (2C), 135.2 (4C), 138.0/138.3, 146.4/146.9, 
152.3/152.9, 173.3/173.7, 200.1/200.5; IR (CHCl3) umax 2956, 2930, 2858, 1744, 
1696, 1381, 1109 (cm-1); MS (FAB) m/z 770 ([M+1]+, 57), 670 (20), 248 (75), 91 
(100); HRMS (FAB) calcd for C46H64NO7Si 770.4452 ([M+H]





To a solution of 52 (2.00 g, 2.61 mmol) in MeOH (10 mL) was added 10% Pd/C 
(1.00 g, 50% wt. of 52). The flask was evacuated, filled with H2, and stirred at rt 
for 12 h. The mixture was then filtered through Celite. The filtrate was 
concentrated and the residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc, 1:1) to give 50 (1.51 g, 85%) as a colorless oil: [a]24D –
14.3 (c 1.0, CHCl3); 
1H NMR (CDCl3, 400 MHz; two rotamers in a 3:2 ratio) δ 
0.88 (t, J = 7.24 Hz, 3H), 1.01 (s, 9H), 1.06–1.17 (m, 1H), 1.24–1.32 (m, 3H), 1.35 
and 1.37 (each s, total 9H in a 3:2 ratio), 1.47–1.52 (m, 3H), 1.63 (s, 2H), 1.71–
1.83 (m, 2H), 1.89–2.16 (m, 3H), 2.22–2.41 (m, 3H), 2.42–2.53 (m, 1H), 2.61–2.75 
(m, 1H),  3.44 (t, J = 10.8 Hz, 0.6H), 3.54–3.65 (m, 3H), 3.67 and 3.71 (each s, 
total 3H in a 3:2 ratio), 3.83–3.99 (m, 1.4H), 4.08 (br d, J = 11.5 Hz, 0.4H), 4.24–
4.31 (m, 0.6H), 7.31–7.44 (m, 6.6H), 7.57–7.66 (m, 3.4H); 13C NMR (CDCl3, 100 
MHz; rotamer 1/rotamer 2) δ 13.7, 19.0, 22.2, 25.7/25.9, 26.7 (3C), 27.2/27.5, 
28.2/28.3 (3C), 31.5/31.6, 39.2, 40.9, 42.2/42.3, 43.4/43.5, 52.1/52.6, 61.3, 63.3, 
63.9/64.2, 64.6/65.1, 73.1/73.4, 80.3/80.9, 95.9, 127.4 (4C), 129.4 (2C), 
133.5/133.6 (2C), 135.3 (4C), 152.8/153.6, 175.2/177.1, 210.9/211.2; IR (CHCl3) 
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umax 3455, 2956, 2859, 1696, 1388, 1110 (cm
-1); MS (FAB) m/z 682 ([M+1]+, 5), 
582 (100), 524 (20), 135 (45), 57 (90); HRMS (FAB) calcd for C39H60NO7Si 
682.4139 ([M+H]+), found 682.4118. 
 
Reagent-controlled diastereoselective reductive amination. 
 
To a solution of 50 (1.50 g, 2.20 mmol) in dry CH2Cl2 (15 mL) was added TFA (9 
mL) at 0 °C. The reaction mixture was stirred at rt for 1 h, and the solvent and 
reagent were removed under reduced pressure. The resulting residue 55 was 
dissolved in MeCN (15 mL) and acetic acid (20 mL). To this solution was added 
NaCNBH3 (483 mg, 7.70 mmol) at –78 °C. The reaction mixture was stirred for 1 h 
at the same temperature and then warmed to rt. The resulting mixture was 
quenched with aqueous saturated NH4Cl solution. It was poured into brine, and 
extracted with EtOAc twice. The combined organic layers were dried over Na2SO4 
and concentrated under reduced pressure. The resulting residue was filtered 
through a short pad of silica using EtOAc and the filtrate was concentrated under 
reduced pressure. 1H NMR analysis of the crude mixture verified the presence of 
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major isomer 53a and minor isomer 53b (53a/53b, 5:1). The residue was further 
purified by flash column chromatography on silica gel (hexane/EtOAc, 2:1) to give 
the major isomer 53a (625 mg, 50%) and a minor isomer 53b (124 mg, 10%). The 
stereochemistry of the 53a and 53b were assigned by COSY, NOESY 2D 




[a]20D –13.1 (c 1.0, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ 0.82–0.89 (m, 3H), 
1.01 (s, 9H), 1.11–1.31 (m, 9H), 1.32–1.59 (m, 4H), 1.62–1.81 (m, 4H), 1.99–2.11 
(m, 1H), 2.21–2.31 (m, 1H), 2.95 (br s, 1H), 3.07–3.16 (m, 1H), 3.32–3.45 (m, 2H),  
3.59 (t, J = 7.01 Hz, 3H), 3.63 (s, 3H), 7.32–7.43 (m, 7H), 7.59–7.66 (m, 3H); 13C 
NMR (CDCl3, 75 MHz) δ 14.1, 19.1, 22.9, 26.8 (3C), 26.9, 27.1, 28.4, 28.6, 29.1, 
31.2, 33.9, 34.5, 40.0, 51.3, 54.9, 56.4, 63.8, 66.2, 73.1, 127.5 (4C), 129.5 (2C), 
133.9 (2C), 135.5 (4C), 175.0; IR (CHCl3) umax 3433, 2932, 2858, 1724, 1428, 
1110 (cm-1); MS (FAB) m/z 566 ([M+1]+, 100), 534 (75), 506 (80), 135 (65), 55 
(90); HRMS (FAB) calcd for C34H52NO4Si 566.3666 ([M+H]







[a]20D –29.9 (c 0.5, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ 0.81–0.89 (m, 3H), 
1.01 (s, 9H), 1.11–1.31 (m, 6H), 1.32–1.48 (m, 5H), 1.62–1.91 (m, 6H), 2.13–2.23 
(m, 1H), 2.25–2.35 (m, 1H), 2.61–2.71 (m, 1H), 3.12–3.17 (m, 1H), 3.32 (d, J = 
10.3 Hz, 2H),  3.49–3.55 (m, 1H), 3.56–3.71 (m, 5H),, 7.32–7.44 (m, 6H), 7.59–
7.67 (m, 4H); 13C NMR (CDCl3, 75 MHz) δ 14.1, 18.9, 19.1, 22.0, 22.8, 25.9, 26.8 
(3C), 27.3, 27.1, 28.3, 29.3, 30.8, 31.9, 33.0, 35.8, 40.0, 51.3, 54.8, 63.9, 69.7, 
127.5 (4C), 129.4 (2C), 134.7 (2C), 135.5 (4C), 176.5; IR (CHCl3) umax 3448, 2931, 
2857, 1736, 1428, 1111 (cm-1); MS (FAB) m/z 566 ([M+1]+, 100), 534 (30), 506 





butyldiphenylsilyloxy) propyl)octahydroindolizine-8a-carboxylate (S21). 
 
To a solution of 53a (5.00 mg, 8.84 mmol) in CH2Cl2 (200 mL) was added 
benzyl trichloroacetimidate (5.00 mL, 26.5 mmol), TMSOTf (0.750 mL, 3.5 
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mmol) at 0 °C. After being stirred for 2 h at rt, the reaction was quenched 
with brine at 0 °C and then the mixture was extracted with CH2Cl2 twice. 
The combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 5:1) to give S21 (4.95 
mg, 90%) as a light yellow oil: 1H NMR (CDCl3, 400 MHz) δ 0.81–0.89 (m, 
3H), 1.01 (s, 9H), 1.11–1.48 (m, 13H), 1.57–1.72 (m, 6H), 1.92–2.07 (m, 
1H), 2.45 (ddd, J = 6.08, 8.08, 12.2 Hz, 1H), 2.87 (t, J = 9.04 Hz, 1H), 3.31 
(m, 1H), 3.43–3.48 (m, 1H), 3.49 (s, 3H), 3.52–3.63 (m, 2H), 4.44 (s, 2H), 
7.28–7.44 (m, 11H), 7.59–7.67 (m, 4H). 
 
(3S,5S,8S,8aS)-methyl 3-(benzyloxymethyl)-5-butyl-8-(3-(tert-
butyldiphenylsilyloxy) propyl)octahydroindolizine-8a-carboxylate (S22). 
 
To a solution of 53a (20.0 mg, 35.3 mmol) in CH2Cl2 (500 mL) was added 
benzyl trichloroacetimidate (21.1 mL, 0.159 mmol), TMSOTf (3.12 mL, 14.1 
mmol) at 0 °C. After being stirred for 2 h at rt, the reaction was quenched 
with brine at 0 °C and then the mixture was extracted with CH2Cl2 twice. 
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The combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 5:1) to give S22 (20.3 
mg, 88%) as a light yellow oil: 1H NMR (CDCl3, 400 MHz) δ 0.82 (t, J = 
6.92 Hz, 3H), 1.01 (s, 9H), 1.08–1.26 (m, 7H), 1.31–1.46 (m, 6H), 1.58–
1.79 (m, 6H), 1.86–1.95 (m, 1H), 2.21–2.29 (m, 1H), 2.73 (m, 1H), 3.15–
3.22 (m, 1H), 3.25 (t, J = 8.32 Hz, 1H), 3.41 (dd, J = 4.16, 8.92 Hz, 1H), 
3.56 (s, 3H), 3.58–3.64 (m, 2H), 4.49 (s, 2H), 7.28–7.42 (m, 11H), 7.60–
7.66 (m, 4H). 
 













To a solution of alcohol 53a (620 mg, 1.09 mmol) in anhydrous DMF (10 mL) 
was added a NaH (130 mg, 3.27 mmol, 60% dispersion in mineral oil) at 0 °C 
under N2 atmosphere. The resulting mixture was stirred for 2 h at rt and then 
quenched with aqueous saturated NH4Cl solution at 0 °C. The aqueous phase was 
extracted with CH2Cl2 twice, and the combined organic layers were dried over 
Na2SO4. The solvent was concentrated under reduced pressure and the residue was 
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purified by flash column chromatography on silica gel (hexane/EtOAc, 2:1) to give 
56 (524 mg, 90%) as a light yellow oil: [a]24D –48.5 (c 1.0, CHCl3); 
1H NMR 
(CDCl3, 500 MHz) δ 0.89 (t, J = 6.85 Hz, 3H), 1.02 (s, 9H), 1.11–1.44 (m, 9H), 
1.57–1.77 (m, 5H), 1.79–1.88 (m, 3H), 2.05–2.15 (m, 1H), 2.24 (ddd, J = 4.75, 
10.0, 13.9 Hz, 1H), 2.52–2.62 (m, 1H), 3.59 (dd, J = 2.95, 7.25 Hz, 1H), 3.62–3.69 
(m, 2H),  4.02 (d, J = 11.2 Hz, 1H), 4.60 (dd, J = 2.21, 11.1 Hz, 1H), 7.32–7.41 
(m, 6H), 7.64 (d, J = 6.65 Hz, 4H); 13C NMR (CDCl3, 75 MHz) δ 14.0, 19.1, 23.0, 
26.4, 26.6, 26.8 (3C), 27.1, 27.6, 31.1, 31.7, 33.6, 35.8, 46.9, 52.6, 55.4, 63.9, 69.7, 
70.8, 127.5 (4C), 129.4 (2C), 134.1 (2C), 135.5 (4C), 171.8; IR (CHCl3) umax 2933, 
2860, 1742, 1428, 1109 (cm-1); MS (FAB) m/z 534 ([M+1]+, 70), 476 (95), 456 (70), 




Synthesis of Compound 57. 
 
To a solution of 56 (510 mg, 0.952 mmol) in THF (5 mL) was added TBAF (2.85 
mL, 2.85 mmol, 1.0 M solution in THF) at 0 °C. The solution was stirred for 3 h at 
rt, and then the reaction mixture was quenched with aqueous saturated NH4Cl 
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solution and extracted with EtOAc twice. The combined organic layers were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc, 1:3) to 
afford alcohol 57 (247 mg, 88%) as a colorless oil: [a]24D –33.1 (c 0.8, CHCl3); 
1H 
NMR (CDCl3, 400 MHz) δ 0.88 (t, J = 6.84 Hz, 3H), 1.15–1.46 (m, 10H), 1.57–
1.73 (m, 3H), 1.74–1.91 (m, 5H), 2.07–2.17 (m, 1H), 2.24 (ddd, J = 4.72, 10.0, 
13.4 Hz, 1H), 2.53–2.62 (m, 1H), 3.58–3.68 (m, 3H), 4.04 (d, J = 11.2 Hz, 1H), 
4.61 (dd, J = 2.01, 11.2 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 14.0, 23.0, 26.4, 
26.5, 27.1, 27.8, 31.0, 31.9, 33.5, 35.9, 46.9, 52.6, 55.3, 63.0, 69.7, 70.8, 171.9; IR 
(CHCl3) umax 3408, 2933, 2865, 1739, 1457, 1168 (cm
-1); MS (FAB) m/z 296 
([M+1]+, 15), 176 (20), 154 (100), 136 (70); HRMS (FAB) calcd for C17H30NO3 
296.2226 ([M+H]+), found 296.2218. 
 
Synthesis of Compound 58. 
 
To a solution of compound 57 (240 mg, 0.808 mmol), imidazole (165 mg, 2.42 
mmol), and triphenylphosphine (423 mg, 1.62 mmol) in CH2Cl2 (4 mL) was added 
a solution of iodine (407 mg, 1.62 mmol) in CH2Cl2 (2 mL) dropwise at 0 °C. The 
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reaction mixture was stirred at rt overnight and quenched with a aqueous saturated 
Na2SO3 solution, extracted with EtOAc twice. The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 4:1) to give 58 (317 mg, 97%) as a colorless oil: [a]20D –34.7 (c 
3.0, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ 0.88 (t, J = 6.80 Hz, 3H), 1.11–1.39 (m, 
8H), 1.57–2.02 (m, 9H), 2.07–2.17 (m, 1H), 2.24 (ddd, J = 4.64, 10.0, 13.9 Hz, 1H), 
2.52–2.61 (m, 1H), 3.11–3.21 (m, 2H), 3.61 (dd, J = 2.96, 7.21 Hz, 1H), 4.04 (d, J 
= 11.2 Hz, 1H), 4.61 (dd, J = 2.01, 11.3 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 
6.66, 14.0, 23.0, 26.4, 26.5, 27.1, 30.9, 32.6, 32.8, 33.5, 35.9, 46.0, 52.6, 55.3, 69.5, 
70.9, 171.8; IR (CHCl3) umax 2933, 2864, 1739, 1457, 1167 (cm
-1); MS (FAB) m/z 
406 ([M+1]+, 100), 404 (60), 378 (85), 206 (70); HRMS (FAB) calcd for 
C17H29INO2 406.1243 ([M+H]





To a solution of 58 (310 mg, 0.764 mmol) in anhydrous THF (10 mL) was added 
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t-BuLi (0.940 mL, 1.61 mmol, 1.7 M solution in pentane) at –100 °C under N2 
atmosphere. The reaction mixture was warmed up to –50 °C in 1 h and quenched 
with aqueous saturated NH4Cl solution and then the mixture was extracted with 
EtOAc twice. The combined organic layers were washed with brine, dried over 
Na2SO4, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography on silica gel (CH2Cl2/MeOH, 10:1) to give 59 (128 
mg, 60%) as a colorless oil: [a]20D +21.4 (c 0.3, CHCl3); 
1H NMR (CDCl3, 400 
MHz) δ 0.82–0.93 (m, 3H), 1.12–1.37 (m, 8H), 1.38–1.44 (m, 1H), 1.56–1.89 (m, 
7H), 1.92–2.21 (m, 4H), 2.28–2.41 (m, 2H), 2.77–2.86 (m, 1H), 3.30 (d, J = 10.3 
Hz, 1H), 3.40 (d, J = 8.96 Hz, 1H), 3.50 (dd, J = 3.60, 10.1 Hz, 1H); 13C NMR 
(CDCl3, 75 MHz) δ 14.0, 21.5, 22.9, 26.8, 28.4, 29.1, 29.3, 29.6, 34.4, 35.3, 39.9, 
41.0, 55.4, 55.6, 66.8, 76.1, 212.9; IR (CHCl3) umax 3388, 2931, 2866, 1707, 1456, 
1149 (cm-1); MS (FAB) m/z 280 ([M+1]+, 100), 220 (15), 136 (10); HRMS (FAB) 
calcd for C17H30NO2 280.2277 ([M+H]
+), found 280.2278. 
 
Proposed Polycitorol A (5a). 
 
A solution of compound 59 (120 mg, 0.428 mmol), KOH (1.20 g, 21.4 mmol) and 
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hydrazine monohydrate (2.10 mL, 42.8 mmol) in ethylene glycol (10 ml) was 
heated at 160 °C for 1h, then the temperature was raised to 190 °C for 1 h to 
remove the distillable material. The remaining solution was heated at 210 °C for 5 
h. After cooling down to rt, 20 mL water was added. The mixture was extracted 
with CH2Cl2 twice and the extract was dried over Na2SO4, concentrated under 
reduced pressure. The residue was purified by flash column chromatography on 
silica gel (CH2Cl2/MeOH/28% aqueous NH3, 100:10:1) to give proposed 5a (74.0 
mg, 65%) as a colorless oil: [a]24D +17.2 (c 0.2, CHCl3); 
1H NMR (CD3OD, 400 
MHz) δ 0.92 (t, J = 5.72 Hz, 3H), 1.17–1.28 (m, 2H), 1.30–1.47 (m, 11H), 1.55–
1.64 (m, 3H), 1.66–1.82 (m, 4H), 2.05–2.18 (m, 3H), 2.91–2.99 (m, 1H), 3.25 (dd, 
J = 5.88, 8.12 Hz, 1H), 3.32–3.39 (m, 1H), 3.49 (dd, J = 1.68, 8.28 Hz, 1H); 13C 
NMR (CD3OD, 125 MHz) δ 15.1, 22.4, 24.7, 26.7, 27.7, 28.8, 29.0, 31.5, 31.7, 
33.8, 36.4, 36.6, 36.7, 57.3, 59.6, 68.3, 69.1; IR (CHCl3) umax 3375, 2930, 2858, 
1670, 1456, 1028 (cm-1); MS (FAB) m/z 266 ([M+1]+, 55), 234 (70), 208 (15), 55 
(100); HRMS (FAB) calcd for C17H32NO 266.2484 ([M+H]
+), found 266.2472. 
 
Proposed Polycitorol A Hydrochloride. 
The free base 5a (10.0 mg, 37.0 mmol) was dissolved in MeOH (1 mL). To this 
solution was added 1.0 M aqueous HCl (50 mL), and then the solution was 
evaporated to dryness in vacuo to give the hydrochloride salt of 5a as a white gum: 
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[a]24D +19.6 (c 0.4, CHCl3); 
1H NMR (CD3OD, 400 MHz) δ 0.95 (t, J = 7.04 Hz, 
3H), 1.25–1.64 (m, 10H), 1.65–2.08 (m, 8H), 2.25 (dt, J = 4.44, 12.7, 16.9 Hz, 1H),  
2.36–2.49 (m, 4H), 2.55 (dd, J = 7.80, 12.9 Hz, 1H), 3.49 (t, J = 11.9 Hz, 1H), 3.74 
(dd, J = 1.80, 11.8 Hz, 1H), 3.80 (dd, J = 3.68, 11.8 Hz, 1H), 4.05 (br d, J = 10.2 
Hz, 1H); 13C NMR (CD3OD, 75 MHz) δ 15.0, 21.5, 24.4, 25.7, 25.9, 26.2, 28.1, 
30.3, 30.5, 31.4, 34.1, 34.8, 36.2, 60.8, 62.7, 64.3, 78.3; IR (CHCl3) umax 3277, 
2938, 2866, 1458, 1086 (cm-1); MS (FAB) m/z 266 ([M]+, 55), 234 (70), 208 (15), 
55 (100); HRMS (FAB) calcd for C17H32NO 266.2484 ([M]
+), found 266.2490. The 
comparison of the 1H and 13C NMR spectra of our synthetic compound 5a and 5a-
HCl salt with those of the natural material indicated that the compounds were 
clearly different. (see, Copies of spectra section (S115)) The identity of synthetic 
compound 5a was further confirmed by the comparison of the NMR spectra of its 
hydrochloride salt with the literature spectra of the hydrochloride salt of 46 which 
differ only by the alkyl chain (Hexyl vs. Butyl) (see; Copies of spectra section 







Proposed Polycitorol B (5b). 
 
To a solution of 5a (40.0 mg, 0.150 mmol) in THF (2 mL) was added dropwise 
TFAA (3.15 mL, 15.0 mmol) at 0 °C. The reaction mixture was heated at 120 °C in a 
sealed-tube for 3 h. After cooling down to 0 °C, and then quenched with saturated 
15% NaOH solution. The aqueous phase was extracted twice with CH2Cl2, and the 
combined organic layers were dried over Na2SO4. The solvent was concentrated 
under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (CH2Cl2/MeOH/28% aqueous NH3, 100:10:1) to give 
proposed 5b (28.0 mg, 60%, 90% based on recovered starting material) as a light 
yellow oil: [a]20D +3.58 (c 0.47, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ 0.89 (t, J = 
6.76 Hz, 3H), 1.19–1.37 (m, 10H), 1.38–1.86 (m, 13H), 2.02 (s, 1H), 2.02 (br d, 
7.58 Hz, 1H), 2.56–2.66 (m, 1H), 3.01 (dd, J = 4.32, 11.4 Hz, 1H), 3.72 (hepet, J = 
4.56 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 14.1, 20.4, 22.4, 23.1, 25.6, 26.6, 27.6, 
28.4, 28.7, 29.6, 30.5, 30.8, 34.1, 48.3, 53.6, 56.1, 68.2; IR (CHCl3) umax 3368, 
2938, 2828, 1469 (cm-1); MS (FAB) m/z 266 ([M]+, 20), 250 (100), 208 (35); 
HRMS (FAB) calcd for C17H32NO 266.2484 ([M]
+), found 266.2479.  
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IV-7. Geometry optimization and energy minimization using 
DMol3 program 
Theoretical calculations of two half-chair conformations 50′A and 50′B were 
performed by the DMol3 program using the Material Studio 6.1TM package. A 
generalized gradient approximation (GAA) for the exchange correlation function of 
Perdew, Burke, and Ernzerhof (PBE) was used with the double-numerical plus d-
functions polarization (DNP) as implemented in DMol3. The computational energy 
minimization using the DMol3 program demonstrates that product 50a′A is 
thermodynamically more stable than the other conformer 50a′B. The energy 






compound Hartree (Ha) kcal/mol Relative energy (kcal/mol) 
50a′A –603.0873895 –378443.0005 0 












We also performed the identical procedure for computational study to verify 
whether compound 50b′A is thermodynamically more stable than the other 















compound Hartree (Ha) kcal/mol Relative energy (kcal/mol) 
50b′A –634.4458177 –398120.7087 0 













50c′A and 50c′B were calculated to compare their energy levels. We can conclude 
that 50c′A is conformationally more stable than the other conformer, 50c′B. The 














compound Hartree (Ha) kcal/mol Relative energy (kcal/mol) 
50c′A –1430.565222 –897693.1114 0 













All calculations are performed under following conditions. 
# Task parameters 
Calculate optimize 
Opt_energy_convergence 1.0000e–005 
Opt_gradient_convergence            2.0000e–003 A 
Opt_displacement_convergence        5.0000e–003 A 
Opt_iterations                     50 
Opt_max_displacement               0.3000 A 
Symmetry                        off 
Max_memory 2048 
 
# Electronic parameters 
Spin_polarization                  restricted 
Charge                          1 
Basis                           dnp 
Pseudopotential                    none 
Functional                        pbe 
Aux_density                     octupole 
Integration_grid                   fine 
Occupation                       fermi 
Cutoff_Global                 3.7000 angstrom 
Scf_density_convergence        1.0000e–006 
Scf_charge_mixing              2.0000e–006 
Scf_iterations                 50 
Scf_diis                      6 pulay 
 







Atom X Y Z Atom X Y Z  
C -3.492452 0.328195 1.155925 H -3.26427 6.304304 -5.763496  
C -1.06936 1.274162 -0.109669 C 0.988402 4.536245 -3.050402  
C -1.323374 3.549603 -1.772139 H 0.795713 6.553679 -3.491525  
N -3.529047 4.568595 -2.174734 C 1.582505 3.052785 -5.515613  
C -5.987911 3.562636 -1.149689 H 2.599903 4.337858 -1.755574  
C -5.772654 0.765782 -0.563889 C 3.86114 4.164889 -6.909458  
C -7.871769 4.411833 -3.162015 H -0.078671 3.065965 -6.770419  
C -6.904536 7.039988 -3.904735 H 1.951063 1.061146 -5.041976  
C -4.020901 6.762134 -3.888174 H 3.447701 6.134991 -7.448047  
H -3.286207 -1.680241 1.62677 C 4.579108 2.645667 -9.263712  
H -3.781235 1.328308 2.956157 H 5.491236 4.247047 -5.615572  
H 0.41467 1.696812 1.288007 H 2.929119 2.490809 -10.528933  
H -0.224838 -0.202605 -1.318869 H 5.066629 0.696504 -8.707666  
H -6.337616 4.628107 0.609632 C 6.794372 3.808089 -10.722068  
H -5.576435 -0.305671 -2.33964 H 6.283575 5.740872 -11.3094  
H -7.526893 0.131286 0.342364 C 7.561975 2.256117 -13.032202  
H -7.819724 3.107132 -4.780697 H 8.42449 4.008277 -9.44077  
H -9.809998 4.440434 -2.428618 H 5.991959 2.079337 -14.382823  
H -7.502816 8.452391 -2.504407 H 8.146193 0.336351 -12.489395  
H -7.591971 7.66667 -5.755646 H 9.153817 3.140163 -14.030167  







Atom X Y Z Atom X Y Z  
C -0.334341 5.320063 1.19777 H -4.643687 3.0074 -5.648128  
C 0.775423 6.411938 -1.244636 C 0.2602 5.159039 -5.924816  
C -0.893725 5.82602 -3.448007 H -1.048259 5.497727 -7.497448  
N -3.328934 5.765763 -3.090221 C 1.187048 2.374381 -5.990393  
C -4.644654 6.4647 -0.672221 H 1.907074 6.400316 -6.200154  
C -2.943255 6.449455 1.688597 C 2.633887 1.789656 -8.428271  
C -6.934378 4.710538 -0.730262 H -0.442667 1.091061 -5.810593  
C -7.73713 4.793086 -3.51191 H 2.412646 2.006546 -4.3491  
C -5.235241 4.879878 -4.98058 H 1.428648 2.212515 -10.075417  
H -0.440144 3.249768 1.022845 C 3.523123 -0.958982 -8.560686  
H 0.926686 5.724843 2.792883 H 4.278153 3.062533 -8.5685  
H 0.98461 8.484718 -1.093848 H 1.873696 -2.230862 -8.46201  
H 2.673317 5.672978 -1.641437 H 4.688684 -1.391687 -6.885721  
H -5.31571 8.406553 -1.015433 C 5.041874 -1.547214 -10.954718  
H -3.91197 5.414176 3.204962 H 3.883603 -1.098389 -12.628312  
H -2.719785 8.402415 2.356727 C 5.909169 -4.29827 -11.084318  
H -6.369423 2.790325 -0.156362 H 6.695299 -0.282923 -11.042096  
H -8.418241 5.353922 0.564702 H 4.289348 -5.59981 -11.082448  
H -8.845955 6.509451 -3.882122 H 7.114135 -4.786765 -9.462166  
H -8.894262 3.171469 -4.077253 H 7.00471 -4.657585 -12.812004  






Atom X Y Z Atom X Y Z  
C 2.97345 4.558749 -5.603278 H -2.594954 9.734198 -5.267348  
C 2.989459 4.012251 -2.767158 H -4.522075 7.888768 -7.294321  
C 0.533384 4.301807 -1.412721 H -6.932687 6.236951 -3.783409  
N -1.491902 5.135529 -2.548302 H -6.159143 9.211965 -2.488407  
C -1.572469 5.770824 -5.305246 H -4.750991 4.552612 -0.272517  
C 1.051927 6.600644 -6.234934 H -3.089516 7.426006 0.267546  
C -3.569904 7.909595 -5.457648 C 0.472754 3.813648 1.359091  
C -5.348325 7.45134 -3.217988 H 2.246327 2.965801 2.00117  
C -3.756363 6.119215 -1.201956 H 0.182093 5.588802 2.412301  
H 4.877947 5.129939 -6.200627 H -1.101858 2.554949 1.862039  
H 2.538877 2.82226 -6.661453 O -2.956999 1.419245 -5.424432  
H 3.74596 2.117391 -2.348289 O -2.792177 3.609869 -9.130164  
H 4.279611 5.305377 -1.747987 C -3.792634 -0.807075 -6.833127  
C -2.513996 3.478004 -6.860364 H -2.324723 -1.377606 -8.178298  
H 0.936207 6.928819 -8.278807 H -5.543461 -0.381185 -7.854073  





Atom X Y Z Atom X Y Z  
C 2.629894 4.399798 -3.086532 H -2.094316 7.765132 -2.305883  
C 2.050983 1.602558 -3.468067 H -3.219128 9.059082 -5.199006  
C -0.744411 1.207478 -3.563548 H -6.900205 6.392519 -5.166905  
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N -2.296203 2.87166 -4.548453 H -6.449292 6.538327 -1.865172  
C -1.392851 5.36268 -5.54971 H -6.223405 2.038052 -4.879991  
C 1.468431 5.868661 -5.257361 H -5.068765 2.300734 -1.732086  
C -3.044188 7.314345 -4.099066 C -1.762258 -1.140915 -2.397875  
C -5.561293 5.959161 -3.64367 H -3.69686 -1.599332 -2.964002  
C -4.972245 3.119435 -3.629466 H -1.687044 -0.969182 -0.319941  
H 4.680453 4.705616 -3.038104 H -0.513006 -2.730349 -2.878261  
H 1.887106 5.031198 -1.247974 O -3.028676 3.39787 -9.335996  
H 2.911039 0.915041 -5.240862 O -1.67737 7.482939 -9.577004  
H 2.810087 0.396937 -1.958865 C -3.689817 3.501339 -12.018185  
C -2.044178 5.552994 -8.400987 H -1.980183 3.809388 -13.146374  
H 2.451558 5.361035 -7.01648 H -5.031637 5.040817 -12.352909  




Atom X Y Z Atom X Y Z  
C -13.757885 -16.476455 -8.510873 C -14.749308 -7.516179 -3.953304  
N -15.615106 -15.010964 -10.074509 H -10.467521 -4.57297 -4.147683  
C -15.464562 -14.876794 -12.528573 H -8.555039 -6.339076 -1.99923  
C -13.56357 -16.353687 -14.004007 H -11.391565 -4.888089 -0.94386  
C -11.720362 -18.059732 -12.548501 H -10.335937 -10.334244 0.050442  
C -12.828338 -18.797617 -9.983623 H -13.177617 -11.75326 -1.094186  
C -15.299202 -17.195042 -6.131205 H -13.300799 -8.932832 0.719791  
C -17.477517 -15.281443 -5.932271 H -14.740186 -6.324421 -5.657971  
C -17.857477 -14.200237 -8.590042 H -15.650883 -6.421819 -2.425443  
C -11.535143 -14.698846 -7.844087 H -15.953268 -9.173273 -4.319731  
C -17.398196 -13.414196 -13.96959 C -6.771729 -12.950238 -3.182056  
H -12.546616 -15.024205 -15.247363 C -4.363762 -13.913768 -2.679961  
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H -14.735569 -17.472239 -15.326647 C -2.323379 -13.250248 -4.221875  
H -9.903855 -17.088054 -12.296083 C -2.711152 -11.640655 -6.281002  
H -11.319328 -19.753201 -13.679807 C -5.125762 -10.689226 -6.785972  
H -11.42728 -19.803581 -8.826564 C -12.396489 -8.478016 -10.714123  
H -14.093949 -17.168468 -4.445307 C -12.555388 -6.963231 -12.872612  
H -16.032322 -19.126857 -6.354928 C -10.870236 -4.955207 -13.200481  
H -16.959513 -13.753941 -4.633529 C -9.04827 -4.470101 -11.351497  
H -19.223326 -16.157592 -5.235125 C -8.898802 -5.993876 -9.198367  
H -17.970636 -12.126315 -8.595678 H -10.624745 -14.047509 -9.605634  
O -12.397923 -12.625882 -6.384129 H -10.131032 -15.83008 -6.791661  
Si -10.490302 -10.060674 -5.878938 H -8.329911 -13.503054 -1.946996  
H -16.825471 -13.177583 -15.946327 H -4.07539 -15.172924 -1.071615  
H -17.726054 -11.544673 -13.126191 H -0.437137 -13.982554 -3.820561  
C -10.560492 -8.048092 -8.833974 H -1.127921 -11.117883 -7.496232  
C -7.205791 -11.301598 -5.238094 H -5.388401 -9.459065 -8.420104  
C -12.05661 -8.294801 -3.143828 H -13.744902 -10.021445 -10.455765  
H -14.439046 -20.092762 -10.241034 H -14.002592 -7.329298 -14.299811  
H -19.544465 -14.952933 -9.539218 H -10.984544 -3.766317 -14.881908  
H -19.226534 -14.417326 -13.949574 H -7.73659 -2.895195 -11.586538  
C -10.512967 -5.894118 -2.543874 H -7.465636 -5.553904 -7.780014  




Atom X Y Z Atom X Y Z  
C -15.329649 -14.56977 -4.928655 C -12.113153 -12.897772 -14.193549  
N -14.855346 -15.289801 -2.208236 H -8.19648 -9.342234 -14.383499  
C -16.4864 -14.786726 -0.408232 H -10.128197 -6.611114 -13.948565  
 130
C -18.890511 -13.388299 -0.893032 H -10.616111 -8.60797 -16.592985  
C -19.900942 -14.044666 -3.512854 H -14.79798 -7.072178 -12.663452  
C -17.909779 -13.333062 -5.451611 H -16.176668 -10.138029 -12.409814  
C -14.991108 -17.100867 -6.363592 H -15.231567 -8.960024 -15.407814  
C -13.085591 -18.636235 -4.80568 H -10.22518 -13.761903 -14.221044  
C -13.206971 -17.603102 -2.094979 H -12.775809 -12.826664 -16.168643  
C -13.148725 -12.719416 -5.598679 H -13.405121 -14.146578 -13.145843  
C -16.033038 -15.722169 2.208144 C -13.685173 -6.146798 -6.948227  
H -18.547126 -11.333935 -0.74092 C -13.987752 -3.703927 -5.987498  
H -20.21536 -13.85629 0.637986 C -12.083371 -1.907267 -6.333201  
H -21.670844 -13.020131 -3.865621 C -9.897551 -2.557461 -7.665823  
H -20.361017 -16.074994 -3.595693 C -9.599031 -5.005833 -8.613459  
H -17.685354 -11.265374 -5.465352 C -6.263306 -10.341777 -7.187153  
H -16.825349 -18.07656 -6.466712 C -3.979589 -11.475762 -6.480073  
H -14.354867 -16.713734 -8.296552 C -3.396157 -13.915584 -7.30624  
H -11.165505 -18.406342 -5.55709 C -5.116835 -15.220459 -8.833845  
H -13.511431 -20.665856 -4.83095 C -7.394452 -14.07718 -9.539091  
H -11.337235 -17.077904 -1.362548 H -11.303723 -13.634395 -5.248969  
O -13.402783 -12.025282 -8.158297 H -13.276495 -11.059947 -4.330268  
Si -11.182609 -10.158798 -9.593087 H -15.215024 -7.514711 -6.706325  
H -14.061752 -16.215586 2.595262 H -15.715604 -3.193856 -4.981172  
H -17.228311 -17.395338 2.560939 H -12.309475 0.003202 -5.589502  
C -8.017207 -11.603815 -8.748306 H -8.418688 -1.15127 -7.971087  
C -11.4786 -6.864289 -8.256563 H -7.876847 -5.461359 -9.656368  
C -12.07 -10.200406 -13.091732 H -6.680585 -8.442059 -6.499776  
H -18.475975 -13.860092 -7.37558 H -2.65165 -10.441874 -5.286063  
H -14.069501 -18.939156 -0.771504 H -1.609142 -14.795385 -6.768121  
H -16.657906 -14.277666 3.564519 H -4.675165 -17.125199 -9.492954  
C -10.129613 -8.596363 -14.565577 H -8.698064 -15.142461 -10.731211  
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Gas chromatograms for 39a–c 
1. 39a: GC conditions, HP-5 column, 30m × 3.2 mm i.d., Injection 250 °C; 
detector temperature 250 °C; oven temperature: 80 °C increase by 15 °C/min to 
130 °C (3 min), 130 °C increase by 7.0 °C/min to 160 °C, 160 °C (0 min),  
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Table 1 (entry 2). 
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Table 1 (entry 5). 
 
 
2. 39b: GC conditions, HP-5 column, 30m × 3.2 mm i.d., Injection 250 °C; 
detector temperature 250 °C; oven temperature: 50 °C (0.5 min), increase by 
10 °C/min to 150 °C (2 min), 150 °C (2 min) increase by 15 °C/min to 200 °C (3 
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Table 1 (entry 8). 
 
Table 1 (entry 9). 
 
Table 1 (entry 10). 
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Table 1 (entry 11). 
 
Table 1 (entry 12). 
 
Table 1 (entry 13). 
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Table 1 (entry 14). 
 
 
3. 39c: GC conditions, HP-5 column, 30m × 3.2 mm i.d., Injection 250 °C; 
detector temperature 250 °C; oven temperature: 180 °C (0.5 min), increase by 
10 °C/min to 220 °C (0 min), 220 °C (0 min), increase by 1.5 °C/min to 240 °C (3 
min), 240 °C (3 min), increase by 20 °C/min to 280 °C (3 min); flow rate 3, Rt 39c-






Table 1 (entry 15). 
 
Table 1 (entry 16). 
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Table 1 (entry 17). 
 
Table 1 (entry 18). 
 
Table 1 (entry 19). 
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* Comparison of the 1H NMR spectra for the synthetic compounds, 5a 




* Comparison of the NMR spectra for synthetic 5a·HCl (bottom) with 
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 문   
1994년에 된 perhydropyrrolo[2,1-j]quinolone  본 골격  가진 
삼고리 해양 천연물 lepadiformie  in vitro에  다양한 암 포에 
항암활  , in vivo상 cardiovascular effects  보 는 것  보고가 
되었다. 어 1997년 견된 fasicularin  perhydropyrido[2,1-j]quinoline  
조  가지고 , Vero cells에 항하여 cytotoxicity  가지 , DNA 
repair system에 향  미쳐 DNA-damaging  키는 것  알 져 
다. 러한 천연물  좋  생리활 과 trans-1-azadecalin A/B ring 
system  흥미 운 조  해 많  합 적 노 들  어져 다.  
본 논문   같  삼고리 해양 천연물 lepadiformin, fasicularin과 2006년 
견 된 비슷한 계열  신규 천연물 polycitorol A  B  제안된 조  
쉽게  가능한 시 물질  체 택적  효과적  전합  
수행하는 과정에 해 제시하는 논문 다. 
상업적  쉽게 매 가능한 (S)-methyl-N-Boc-pyroglutamate  시  
물질  하여 cyclic amino acid allylic ester  합  하 고,  물질  
Claisene rearrangement  수행하여 다양한 체 조   가능한 첫 
째 핵심 간체  cyclic amino acid  얻었다. 다  reagent-
controlled stereoselective reductive amination  통하여 각  다  물  
만들  한 두 째 핵심 간체 indolizidine  좋  택  얻  
수 었다. 게 얻어진 다양한 indolizidine에 aziridinium-mediated 
 221
carbon homologation과 RCM  통해 lepadiformine과 fasicularin  
효과적  전합  할 수 었 , halogen–metal exchange 고리화  
통해 제안된 polycitorol A, B  합  료 하 다.  
 
주 어: Ester enolate Clasiene rearrangement, Reductive amination, Marine 
alkaloid, Azididinium, Total synthesis 
학 : 2007-30466
 
 
